<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:f9decc57-797a-413c-90b8-420c8725863c,g:09999a2e-4304-4978-bf07-d51110518516-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://darebioscience.com/role/CoverPage" xlink:type="simple" xlink:href="dare-20211231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_3d822d6c-5bd1-4227-a6ac-161d24150d78" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_DocumentType_3d822d6c-5bd1-4227-a6ac-161d24150d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_0d52d93e-0b0c-4432-8fd2-d9dc3ce106ba" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_DocumentAnnualReport_0d52d93e-0b0c-4432-8fd2-d9dc3ce106ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_3fc0536c-3493-436d-ad0d-89eee05a160f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_DocumentPeriodEndDate_3fc0536c-3493-436d-ad0d-89eee05a160f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_ab2b1259-543e-4e85-b8ab-18e28ddf838f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_CurrentFiscalYearEndDate_ab2b1259-543e-4e85-b8ab-18e28ddf838f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_781daa11-10f0-4d8b-b796-3f8e01830714" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_DocumentTransitionReport_781daa11-10f0-4d8b-b796-3f8e01830714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_b0f26b51-0cb8-40c6-aa01-7382f2790047" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_EntityFileNumber_b0f26b51-0cb8-40c6-aa01-7382f2790047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_f3cb417a-b6bc-45ec-896d-493487b0a523" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_EntityRegistrantName_f3cb417a-b6bc-45ec-896d-493487b0a523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ec3d03a9-1dfa-4cca-8c40-dee79a4bd2b0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ec3d03a9-1dfa-4cca-8c40-dee79a4bd2b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_58c4971f-1932-4acc-8732-a8d630c719c1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_EntityTaxIdentificationNumber_58c4971f-1932-4acc-8732-a8d630c719c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_eb7aec85-1404-4912-a9ad-bfda293ddee6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_EntityAddressAddressLine1_eb7aec85-1404-4912-a9ad-bfda293ddee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_22a04336-aef9-406c-8d31-3b3715c69988" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_EntityAddressAddressLine2_22a04336-aef9-406c-8d31-3b3715c69988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_5f363076-866f-41ad-a5e5-8ffd1a75f823" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_EntityAddressCityOrTown_5f363076-866f-41ad-a5e5-8ffd1a75f823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_5a0d57e9-dcdb-4d70-866b-a205efe40b63" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_EntityAddressStateOrProvince_5a0d57e9-dcdb-4d70-866b-a205efe40b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_a7e38939-768f-4556-b5b7-f8046e3e96ca" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_EntityAddressPostalZipCode_a7e38939-768f-4556-b5b7-f8046e3e96ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_d36a73f3-18da-40ca-86b7-4a8b225c154c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_CityAreaCode_d36a73f3-18da-40ca-86b7-4a8b225c154c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b18135fb-f8e0-433c-bdd5-fac6645f2be2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_LocalPhoneNumber_b18135fb-f8e0-433c-bdd5-fac6645f2be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_fffb2ffb-e957-439d-bb67-225740c91249" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_Security12bTitle_fffb2ffb-e957-439d-bb67-225740c91249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_5dcb1e5a-8e3f-4e06-95b8-9c6cb998bbaf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_TradingSymbol_5dcb1e5a-8e3f-4e06-95b8-9c6cb998bbaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_bf40ac42-4985-40e1-9f85-c35eccfe3705" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_bf40ac42-4985-40e1-9f85-c35eccfe3705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_e94325e3-01a0-478e-a5c7-f4b4ff7989e8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_EntityVoluntaryFilers_e94325e3-01a0-478e-a5c7-f4b4ff7989e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_7268160d-997f-41cf-ad63-11047a83ebb1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_EntityCurrentReportingStatus_7268160d-997f-41cf-ad63-11047a83ebb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_14be0bea-3a61-43ea-9126-2f06afc1e9f8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_EntityInteractiveDataCurrent_14be0bea-3a61-43ea-9126-2f06afc1e9f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_a371c5ba-c00a-4526-8998-9c91c535a7ac" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_EntityFilerCategory_a371c5ba-c00a-4526-8998-9c91c535a7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_a5383da0-ae32-415c-aff7-80ddd208822a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_EntitySmallBusiness_a5383da0-ae32-415c-aff7-80ddd208822a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d4c76228-b7a1-40b3-88b1-82ac991a7240" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_EntityEmergingGrowthCompany_d4c76228-b7a1-40b3-88b1-82ac991a7240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_d41b4c94-541e-4812-8ad1-6da28e034b8b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_IcfrAuditorAttestationFlag_d41b4c94-541e-4812-8ad1-6da28e034b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_26443784-b386-4366-bbae-021b03b2a09a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_EntityShellCompany_26443784-b386-4366-bbae-021b03b2a09a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_e0c1c1c6-b50c-4201-a81f-79813dfe155e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_EntityPublicFloat_e0c1c1c6-b50c-4201-a81f-79813dfe155e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_c060122c-fe0b-4912-b95a-bddb79a4dd0a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_c060122c-fe0b-4912-b95a-bddb79a4dd0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_1f7f0698-d15d-4f18-b361-bb3015a126c4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_1f7f0698-d15d-4f18-b361-bb3015a126c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b6b09b17-dca9-4c66-868d-0cdb4edd0469" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_AmendmentFlag_b6b09b17-dca9-4c66-868d-0cdb4edd0469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_f76bfe92-4038-4914-b6d8-03faf113012d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_DocumentFiscalYearFocus_f76bfe92-4038-4914-b6d8-03faf113012d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_5609384e-298c-4538-8ab7-5a8b82d09ee4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_DocumentFiscalPeriodFocus_5609384e-298c-4538-8ab7-5a8b82d09ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7b9d65f7-da2c-48f1-9634-ae5ca5469707" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7366666f-6003-40ca-8e5b-5949b239affa" xlink:to="loc_dei_EntityCentralIndexKey_7b9d65f7-da2c-48f1-9634-ae5ca5469707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/AuditInformation" xlink:type="simple" xlink:href="dare-20211231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dare_AuditInformationAbstract_1bd048d2-7214-485e-aa7d-05beb72a3b4c" xlink:href="dare-20211231.xsd#dare_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_a6b81651-6cec-4183-88fb-22992e40526a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_AuditInformationAbstract_1bd048d2-7214-485e-aa7d-05beb72a3b4c" xlink:to="loc_dei_AuditorFirmId_a6b81651-6cec-4183-88fb-22992e40526a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_5224caed-3ce8-47fe-9b4c-9ed76984db97" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_AuditInformationAbstract_1bd048d2-7214-485e-aa7d-05beb72a3b4c" xlink:to="loc_dei_AuditorName_5224caed-3ce8-47fe-9b4c-9ed76984db97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_513ba075-e310-430a-a927-13508327c671" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_AuditInformationAbstract_1bd048d2-7214-485e-aa7d-05beb72a3b4c" xlink:to="loc_dei_AuditorLocation_513ba075-e310-430a-a927-13508327c671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="dare-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_3a5626f1-3ae1-4367-b958-006e86abb2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_d97a15da-ae18-4bd1-a4e6-f193ae88af79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3a5626f1-3ae1-4367-b958-006e86abb2f5" xlink:to="loc_us-gaap_AssetsAbstract_d97a15da-ae18-4bd1-a4e6-f193ae88af79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_2ed46f15-d9b0-4adb-b449-655ce6d13ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d97a15da-ae18-4bd1-a4e6-f193ae88af79" xlink:to="loc_us-gaap_AssetsCurrentAbstract_2ed46f15-d9b0-4adb-b449-655ce6d13ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4709ae3b-049a-45b6-814b-5becdf5f2747" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2ed46f15-d9b0-4adb-b449-655ce6d13ff6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4709ae3b-049a-45b6-814b-5becdf5f2747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_d0ab108b-4869-4f25-b420-4fde88961134" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2ed46f15-d9b0-4adb-b449-655ce6d13ff6" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_d0ab108b-4869-4f25-b420-4fde88961134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_3b7b7ba1-0cdb-4ac2-8dc1-aa3adcae11d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2ed46f15-d9b0-4adb-b449-655ce6d13ff6" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_3b7b7ba1-0cdb-4ac2-8dc1-aa3adcae11d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3e7e5f46-be06-4120-8ec5-d5b1322a42ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2ed46f15-d9b0-4adb-b449-655ce6d13ff6" xlink:to="loc_us-gaap_AssetsCurrent_3e7e5f46-be06-4120-8ec5-d5b1322a42ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c17384ec-0857-433c-a90e-c8fc36688362" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d97a15da-ae18-4bd1-a4e6-f193ae88af79" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c17384ec-0857-433c-a90e-c8fc36688362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_b4b926cf-5fc6-402f-aa18-11a948d58805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d97a15da-ae18-4bd1-a4e6-f193ae88af79" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_b4b926cf-5fc6-402f-aa18-11a948d58805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ba4de581-8cac-450d-9a8d-c776f48f5926" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d97a15da-ae18-4bd1-a4e6-f193ae88af79" xlink:to="loc_us-gaap_Assets_ba4de581-8cac-450d-9a8d-c776f48f5926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b0b84512-74a8-4e3c-9505-b21d1acdbf1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3a5626f1-3ae1-4367-b958-006e86abb2f5" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b0b84512-74a8-4e3c-9505-b21d1acdbf1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_7e1ab7fb-3cc2-47e4-8aaf-b72b6f33a502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b0b84512-74a8-4e3c-9505-b21d1acdbf1e" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_7e1ab7fb-3cc2-47e4-8aaf-b72b6f33a502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_45dbd1d9-560e-4c7e-80d3-5200523ec0f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7e1ab7fb-3cc2-47e4-8aaf-b72b6f33a502" xlink:to="loc_us-gaap_AccountsPayableCurrent_45dbd1d9-560e-4c7e-80d3-5200523ec0f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_9e5c44b8-ca98-45be-bc39-efb41693dc79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7e1ab7fb-3cc2-47e4-8aaf-b72b6f33a502" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_9e5c44b8-ca98-45be-bc39-efb41693dc79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_DeferredGrantFundingCurrent_1f6498d0-4312-4393-9e25-d3b236cd180f" xlink:href="dare-20211231.xsd#dare_DeferredGrantFundingCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7e1ab7fb-3cc2-47e4-8aaf-b72b6f33a502" xlink:to="loc_dare_DeferredGrantFundingCurrent_1f6498d0-4312-4393-9e25-d3b236cd180f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_1a68c8ff-1be9-400b-ab70-4e5d2ce761cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7e1ab7fb-3cc2-47e4-8aaf-b72b6f33a502" xlink:to="loc_us-gaap_NotesPayableCurrent_1a68c8ff-1be9-400b-ab70-4e5d2ce761cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_e71e46b0-72af-458a-9917-e80d52e8d221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7e1ab7fb-3cc2-47e4-8aaf-b72b6f33a502" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_e71e46b0-72af-458a-9917-e80d52e8d221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_94c1348d-5735-4569-9fd0-6b04a6e72ace" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7e1ab7fb-3cc2-47e4-8aaf-b72b6f33a502" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_94c1348d-5735-4569-9fd0-6b04a6e72ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bab0013a-31fe-4f3f-bce9-6bb660cdcee8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7e1ab7fb-3cc2-47e4-8aaf-b72b6f33a502" xlink:to="loc_us-gaap_LiabilitiesCurrent_bab0013a-31fe-4f3f-bce9-6bb660cdcee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_75216cac-0322-4a67-af1e-b792fa225e62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b0b84512-74a8-4e3c-9505-b21d1acdbf1e" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_75216cac-0322-4a67-af1e-b792fa225e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ed0c70b4-e655-487f-a247-3eb5f82015d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b0b84512-74a8-4e3c-9505-b21d1acdbf1e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ed0c70b4-e655-487f-a247-3eb5f82015d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_2fbe8190-5b7a-4208-8e43-608736e78476" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b0b84512-74a8-4e3c-9505-b21d1acdbf1e" xlink:to="loc_us-gaap_Liabilities_2fbe8190-5b7a-4208-8e43-608736e78476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_000a3192-03f0-43a2-9700-93d74c999d79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b0b84512-74a8-4e3c-9505-b21d1acdbf1e" xlink:to="loc_us-gaap_CommitmentsAndContingencies_000a3192-03f0-43a2-9700-93d74c999d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_b5115c44-7171-4e66-a77c-d825c1ab3ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b0b84512-74a8-4e3c-9505-b21d1acdbf1e" xlink:to="loc_us-gaap_StockholdersEquityAbstract_b5115c44-7171-4e66-a77c-d825c1ab3ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_c5949cf2-454d-418a-b49a-5f57e1551335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b5115c44-7171-4e66-a77c-d825c1ab3ec7" xlink:to="loc_us-gaap_PreferredStockValue_c5949cf2-454d-418a-b49a-5f57e1551335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_5d3fcf16-f046-4c42-b410-712f2bf559bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b5115c44-7171-4e66-a77c-d825c1ab3ec7" xlink:to="loc_us-gaap_CommonStockValue_5d3fcf16-f046-4c42-b410-712f2bf559bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a89cdd8c-c7df-4b72-bc73-8cb3ca482e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b5115c44-7171-4e66-a77c-d825c1ab3ec7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a89cdd8c-c7df-4b72-bc73-8cb3ca482e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d0fcd27d-69f8-40bc-b6c3-c41ac373ee49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b5115c44-7171-4e66-a77c-d825c1ab3ec7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d0fcd27d-69f8-40bc-b6c3-c41ac373ee49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8e36874c-c240-4d52-bf74-522df0cd7a54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b5115c44-7171-4e66-a77c-d825c1ab3ec7" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8e36874c-c240-4d52-bf74-522df0cd7a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c8e5a955-a591-4971-b2b0-f2cb63e56c57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b5115c44-7171-4e66-a77c-d825c1ab3ec7" xlink:to="loc_us-gaap_StockholdersEquity_c8e5a955-a591-4971-b2b0-f2cb63e56c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_9fe0d90c-09aa-4773-a394-2a94c3dc2c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b0b84512-74a8-4e3c-9505-b21d1acdbf1e" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_9fe0d90c-09aa-4773-a394-2a94c3dc2c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="dare-20211231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_64a49f88-d34f-4321-a4a7-59822ea65e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_c783a84f-4fd2-45b2-863e-96c03515d140" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64a49f88-d34f-4321-a4a7-59822ea65e1c" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_c783a84f-4fd2-45b2-863e-96c03515d140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_15fc0e80-6613-4910-9010-efada1dc13e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64a49f88-d34f-4321-a4a7-59822ea65e1c" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_15fc0e80-6613-4910-9010-efada1dc13e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_50d9c9a7-8c79-44a9-a9c7-c99681e723fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64a49f88-d34f-4321-a4a7-59822ea65e1c" xlink:to="loc_us-gaap_PreferredStockSharesIssued_50d9c9a7-8c79-44a9-a9c7-c99681e723fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_78347a41-903d-4fac-8657-b880b2d32037" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64a49f88-d34f-4321-a4a7-59822ea65e1c" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_78347a41-903d-4fac-8657-b880b2d32037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_2ad6a630-9c46-42ce-9ba2-3848f1079094" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64a49f88-d34f-4321-a4a7-59822ea65e1c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_2ad6a630-9c46-42ce-9ba2-3848f1079094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7f173b3b-2ceb-4b70-b67b-39df959854f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64a49f88-d34f-4321-a4a7-59822ea65e1c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7f173b3b-2ceb-4b70-b67b-39df959854f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_5e47ca64-0311-4beb-af60-caf4894aeb19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64a49f88-d34f-4321-a4a7-59822ea65e1c" xlink:to="loc_us-gaap_CommonStockSharesIssued_5e47ca64-0311-4beb-af60-caf4894aeb19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_091e098e-2b9d-4779-b3b1-97ed0f5a8731" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64a49f88-d34f-4321-a4a7-59822ea65e1c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_091e098e-2b9d-4779-b3b1-97ed0f5a8731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="dare-20211231.xsd#ConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_3b93389d-2bd7-4bcb-ac31-1c5b69ab6ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_7c3f7587-ca06-41a9-8888-82519fbc0af1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b93389d-2bd7-4bcb-ac31-1c5b69ab6ec5" xlink:to="loc_us-gaap_OperatingExpensesAbstract_7c3f7587-ca06-41a9-8888-82519fbc0af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_ea68ca2c-bc87-4c06-93c8-7f40eb6799e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7c3f7587-ca06-41a9-8888-82519fbc0af1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_ea68ca2c-bc87-4c06-93c8-7f40eb6799e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_2f9c2b80-5cf3-4f82-901c-d5c10f7eec5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7c3f7587-ca06-41a9-8888-82519fbc0af1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_2f9c2b80-5cf3-4f82-901c-d5c10f7eec5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_LicenseFee_b6fa57eb-ae4c-4b8b-8263-df40621ff024" xlink:href="dare-20211231.xsd#dare_LicenseFee"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7c3f7587-ca06-41a9-8888-82519fbc0af1" xlink:to="loc_dare_LicenseFee_b6fa57eb-ae4c-4b8b-8263-df40621ff024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_7c5f959f-d073-489f-8eb9-ccb9c7d42734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7c3f7587-ca06-41a9-8888-82519fbc0af1" xlink:to="loc_us-gaap_OperatingExpenses_7c5f959f-d073-489f-8eb9-ccb9c7d42734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_96db09e9-1170-474b-aa99-56c1ca377cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b93389d-2bd7-4bcb-ac31-1c5b69ab6ec5" xlink:to="loc_us-gaap_OperatingIncomeLoss_96db09e9-1170-474b-aa99-56c1ca377cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a9185836-ddf7-4b64-9cd8-67ffbe5cbc7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b93389d-2bd7-4bcb-ac31-1c5b69ab6ec5" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a9185836-ddf7-4b64-9cd8-67ffbe5cbc7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e53ac7f7-97ba-4fab-9afb-6a85942b7700" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b93389d-2bd7-4bcb-ac31-1c5b69ab6ec5" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e53ac7f7-97ba-4fab-9afb-6a85942b7700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6e1ccb67-6033-4a26-9e0f-934a63dac24e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b93389d-2bd7-4bcb-ac31-1c5b69ab6ec5" xlink:to="loc_us-gaap_NetIncomeLoss_6e1ccb67-6033-4a26-9e0f-934a63dac24e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_DeemedDividendFromTriggerOfRoundDownProvisionFeature_cd09545b-3c41-4448-90f2-58b95e83761a" xlink:href="dare-20211231.xsd#dare_DeemedDividendFromTriggerOfRoundDownProvisionFeature"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b93389d-2bd7-4bcb-ac31-1c5b69ab6ec5" xlink:to="loc_dare_DeemedDividendFromTriggerOfRoundDownProvisionFeature_cd09545b-3c41-4448-90f2-58b95e83761a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_23c3c0b4-b649-4cb1-9125-38ec2cf0ea77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b93389d-2bd7-4bcb-ac31-1c5b69ab6ec5" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_23c3c0b4-b649-4cb1-9125-38ec2cf0ea77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6c6f87f4-7358-4e4d-8882-c3912234d37a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b93389d-2bd7-4bcb-ac31-1c5b69ab6ec5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6c6f87f4-7358-4e4d-8882-c3912234d37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ec452f26-e9e2-4b01-ad86-421a187406b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b93389d-2bd7-4bcb-ac31-1c5b69ab6ec5" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_ec452f26-e9e2-4b01-ad86-421a187406b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_429d5ce8-5475-45b1-a816-b47a2dcc9a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b93389d-2bd7-4bcb-ac31-1c5b69ab6ec5" xlink:to="loc_us-gaap_EarningsPerShareBasic_429d5ce8-5475-45b1-a816-b47a2dcc9a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_96976ac2-5df4-45a2-864e-ce23e63d3f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b93389d-2bd7-4bcb-ac31-1c5b69ab6ec5" xlink:to="loc_us-gaap_EarningsPerShareDiluted_96976ac2-5df4-45a2-864e-ce23e63d3f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d4e51db3-b569-4e61-82f0-43321f1a36ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b93389d-2bd7-4bcb-ac31-1c5b69ab6ec5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d4e51db3-b569-4e61-82f0-43321f1a36ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f40bbe3d-5ad6-4e8b-8fd4-71127d538661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d4e51db3-b569-4e61-82f0-43321f1a36ae" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f40bbe3d-5ad6-4e8b-8fd4-71127d538661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2be242e1-394b-49c6-8a86-1be5e29a1c21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d4e51db3-b569-4e61-82f0-43321f1a36ae" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2be242e1-394b-49c6-8a86-1be5e29a1c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/ConsolidatedStatementofStockholdersEquityDeficit" xlink:type="simple" xlink:href="dare-20211231.xsd#ConsolidatedStatementofStockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/ConsolidatedStatementofStockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_fb8890ef-f5ba-456f-a948-d6e93207d0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1f8b2ae3-5729-4c83-a558-ef4d0a9ecd66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_fb8890ef-f5ba-456f-a948-d6e93207d0e4" xlink:to="loc_us-gaap_StatementTable_1f8b2ae3-5729-4c83-a558-ef4d0a9ecd66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b880659c-804f-4151-bb27-7d39dad42b46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1f8b2ae3-5729-4c83-a558-ef4d0a9ecd66" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b880659c-804f-4151-bb27-7d39dad42b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7ea28f66-fe7a-4898-bcbe-debdb5caa0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b880659c-804f-4151-bb27-7d39dad42b46" xlink:to="loc_us-gaap_EquityComponentDomain_7ea28f66-fe7a-4898-bcbe-debdb5caa0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5b16a442-efd4-4886-8bf5-54e419e7f798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7ea28f66-fe7a-4898-bcbe-debdb5caa0d0" xlink:to="loc_us-gaap_CommonStockMember_5b16a442-efd4-4886-8bf5-54e419e7f798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8f8ec525-7906-4da8-910a-53dba6f0296f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7ea28f66-fe7a-4898-bcbe-debdb5caa0d0" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8f8ec525-7906-4da8-910a-53dba6f0296f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1bf458f9-5f3b-4917-b143-726ef01c9b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7ea28f66-fe7a-4898-bcbe-debdb5caa0d0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1bf458f9-5f3b-4917-b143-726ef01c9b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_8f5a3c9e-bda1-4495-93fa-9f0fb41a6a94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7ea28f66-fe7a-4898-bcbe-debdb5caa0d0" xlink:to="loc_us-gaap_RetainedEarningsMember_8f5a3c9e-bda1-4495-93fa-9f0fb41a6a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_96f0f8fe-3feb-42e1-b629-0087af12039c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1f8b2ae3-5729-4c83-a558-ef4d0a9ecd66" xlink:to="loc_us-gaap_StatementLineItems_96f0f8fe-3feb-42e1-b629-0087af12039c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0dd26066-5874-42c5-95f0-768160da39b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_96f0f8fe-3feb-42e1-b629-0087af12039c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0dd26066-5874-42c5-95f0-768160da39b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_97ecbc0d-c171-4edc-a5d0-3e1b3043eb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0dd26066-5874-42c5-95f0-768160da39b1" xlink:to="loc_us-gaap_SharesOutstanding_97ecbc0d-c171-4edc-a5d0-3e1b3043eb3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_da3bcf13-53be-4a22-88c4-83039ff1523a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0dd26066-5874-42c5-95f0-768160da39b1" xlink:to="loc_us-gaap_StockholdersEquity_da3bcf13-53be-4a22-88c4-83039ff1523a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_6107a6a8-1c0a-40ad-a326-54a61ff35c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0dd26066-5874-42c5-95f0-768160da39b1" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_6107a6a8-1c0a-40ad-a326-54a61ff35c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7c55f890-6005-4202-a636-ec2a09acfe32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0dd26066-5874-42c5-95f0-768160da39b1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7c55f890-6005-4202-a636-ec2a09acfe32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_025f5d59-40d6-45d8-8c95-412b99ee2856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0dd26066-5874-42c5-95f0-768160da39b1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_025f5d59-40d6-45d8-8c95-412b99ee2856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_AdjustmentsToAdditionalPaidInCapitalCommonStockAndWarrantsIssuedShares_61f7565b-fe3a-4072-95f9-163ff4b2276c" xlink:href="dare-20211231.xsd#dare_AdjustmentsToAdditionalPaidInCapitalCommonStockAndWarrantsIssuedShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0dd26066-5874-42c5-95f0-768160da39b1" xlink:to="loc_dare_AdjustmentsToAdditionalPaidInCapitalCommonStockAndWarrantsIssuedShares_61f7565b-fe3a-4072-95f9-163ff4b2276c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_d54f2f48-427e-4ee6-9f8a-6f4cca015e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0dd26066-5874-42c5-95f0-768160da39b1" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_d54f2f48-427e-4ee6-9f8a-6f4cca015e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_StockIssuedDuringPeriodSharesConsiderationForCommitmentToPurchaseShares_216eacc6-b379-4eea-aeb1-4e98ab77c426" xlink:href="dare-20211231.xsd#dare_StockIssuedDuringPeriodSharesConsiderationForCommitmentToPurchaseShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0dd26066-5874-42c5-95f0-768160da39b1" xlink:to="loc_dare_StockIssuedDuringPeriodSharesConsiderationForCommitmentToPurchaseShares_216eacc6-b379-4eea-aeb1-4e98ab77c426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_StockIssuedDuringPeriodValueConsiderationForCommitmentToPurchaseShares_37241e80-5e5d-4035-a62a-59a83f508ed6" xlink:href="dare-20211231.xsd#dare_StockIssuedDuringPeriodValueConsiderationForCommitmentToPurchaseShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0dd26066-5874-42c5-95f0-768160da39b1" xlink:to="loc_dare_StockIssuedDuringPeriodValueConsiderationForCommitmentToPurchaseShares_37241e80-5e5d-4035-a62a-59a83f508ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b6cdc176-3e4a-4981-b00e-36c05e5a5259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0dd26066-5874-42c5-95f0-768160da39b1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b6cdc176-3e4a-4981-b00e-36c05e5a5259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_cfe7be92-c657-44cc-b9eb-f570da5217cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0dd26066-5874-42c5-95f0-768160da39b1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_cfe7be92-c657-44cc-b9eb-f570da5217cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_StockIssuedDuringPeriodSharesMilestonePayment_63c3fe1f-1617-440b-aca6-fee2731ac84f" xlink:href="dare-20211231.xsd#dare_StockIssuedDuringPeriodSharesMilestonePayment"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0dd26066-5874-42c5-95f0-768160da39b1" xlink:to="loc_dare_StockIssuedDuringPeriodSharesMilestonePayment_63c3fe1f-1617-440b-aca6-fee2731ac84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_StockIssuedDuringPeriodValueMilestonePayment_017a504a-e80f-4e05-9584-2287ecaa68fc" xlink:href="dare-20211231.xsd#dare_StockIssuedDuringPeriodValueMilestonePayment"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0dd26066-5874-42c5-95f0-768160da39b1" xlink:to="loc_dare_StockIssuedDuringPeriodValueMilestonePayment_017a504a-e80f-4e05-9584-2287ecaa68fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_DeemedDividendFromTriggerOfRoundDownProvisionFeature_7ed10ed6-5f98-4e8a-a765-a9c305bf1b1e" xlink:href="dare-20211231.xsd#dare_DeemedDividendFromTriggerOfRoundDownProvisionFeature"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0dd26066-5874-42c5-95f0-768160da39b1" xlink:to="loc_dare_DeemedDividendFromTriggerOfRoundDownProvisionFeature_7ed10ed6-5f98-4e8a-a765-a9c305bf1b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_85cc4170-c98d-4fde-adab-9e5413d937dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0dd26066-5874-42c5-95f0-768160da39b1" xlink:to="loc_us-gaap_NetIncomeLoss_85cc4170-c98d-4fde-adab-9e5413d937dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_772f975b-889b-427d-8d5e-dba780b16a29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0dd26066-5874-42c5-95f0-768160da39b1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_772f975b-889b-427d-8d5e-dba780b16a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_fce0565e-45b3-4ca5-b0d3-db817fcd525c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0dd26066-5874-42c5-95f0-768160da39b1" xlink:to="loc_us-gaap_SharesOutstanding_fce0565e-45b3-4ca5-b0d3-db817fcd525c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7f939611-4171-42b5-963a-1a4b95819d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0dd26066-5874-42c5-95f0-768160da39b1" xlink:to="loc_us-gaap_StockholdersEquity_7f939611-4171-42b5-963a-1a4b95819d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="dare-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_b6e2e7e5-7cab-4ba7-ad95-85edf26918bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_8b7f3027-6b6c-43de-832d-0f9735ecb14d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b6e2e7e5-7cab-4ba7-ad95-85edf26918bd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_8b7f3027-6b6c-43de-832d-0f9735ecb14d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3b08d479-63aa-41b0-9ac1-af77c5300d24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_8b7f3027-6b6c-43de-832d-0f9735ecb14d" xlink:to="loc_us-gaap_NetIncomeLoss_3b08d479-63aa-41b0-9ac1-af77c5300d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2c908948-fd18-46f5-a3d5-0c2215deb3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_8b7f3027-6b6c-43de-832d-0f9735ecb14d" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2c908948-fd18-46f5-a3d5-0c2215deb3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_5b979b9f-cde3-4191-9374-72dc12a936bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2c908948-fd18-46f5-a3d5-0c2215deb3e8" xlink:to="loc_us-gaap_Depreciation_5b979b9f-cde3-4191-9374-72dc12a936bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_eb95c2f3-7446-4eda-8264-78f93f751e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2c908948-fd18-46f5-a3d5-0c2215deb3e8" xlink:to="loc_us-gaap_ShareBasedCompensation_eb95c2f3-7446-4eda-8264-78f93f751e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_NonCashLeaseExpense_b37ecc44-8641-4277-b518-4429380e71c6" xlink:href="dare-20211231.xsd#dare_NonCashLeaseExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2c908948-fd18-46f5-a3d5-0c2215deb3e8" xlink:to="loc_dare_NonCashLeaseExpense_b37ecc44-8641-4277-b518-4429380e71c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2a40b5ca-8874-450c-a647-3b855fc5a8ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2c908948-fd18-46f5-a3d5-0c2215deb3e8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2a40b5ca-8874-450c-a647-3b855fc5a8ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ba082982-56f8-4fa5-a668-1d8b8e007ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2c908948-fd18-46f5-a3d5-0c2215deb3e8" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ba082982-56f8-4fa5-a668-1d8b8e007ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_95cf0143-cdbc-4084-a19b-5ecac36a0882" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2c908948-fd18-46f5-a3d5-0c2215deb3e8" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_95cf0143-cdbc-4084-a19b-5ecac36a0882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_0635cebe-57ab-4f23-9db1-8ef7180b2f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_95cf0143-cdbc-4084-a19b-5ecac36a0882" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_0635cebe-57ab-4f23-9db1-8ef7180b2f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_1a5bd2a6-5686-4fdd-83f8-dd0c318bdaa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_95cf0143-cdbc-4084-a19b-5ecac36a0882" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_1a5bd2a6-5686-4fdd-83f8-dd0c318bdaa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_d8e3f69a-326a-4d4f-a2ab-8dee191efaa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_95cf0143-cdbc-4084-a19b-5ecac36a0882" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_d8e3f69a-326a-4d4f-a2ab-8dee191efaa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_beebfc59-4e09-4f83-a295-2bbd4a5e6fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_95cf0143-cdbc-4084-a19b-5ecac36a0882" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_beebfc59-4e09-4f83-a295-2bbd4a5e6fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_ec2d0d9f-1271-4b7a-9d92-a645d152cefd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_95cf0143-cdbc-4084-a19b-5ecac36a0882" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_ec2d0d9f-1271-4b7a-9d92-a645d152cefd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_IncreaseDecreaseInDeferredGrantFunding_33e6eb0f-da15-4df1-9a71-3cba5053e60b" xlink:href="dare-20211231.xsd#dare_IncreaseDecreaseInDeferredGrantFunding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_95cf0143-cdbc-4084-a19b-5ecac36a0882" xlink:to="loc_dare_IncreaseDecreaseInDeferredGrantFunding_33e6eb0f-da15-4df1-9a71-3cba5053e60b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_dc3d8315-c779-4935-b306-e17cce447418" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_95cf0143-cdbc-4084-a19b-5ecac36a0882" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_dc3d8315-c779-4935-b306-e17cce447418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_387a2058-2559-4e88-a71c-460eee04bf23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_8b7f3027-6b6c-43de-832d-0f9735ecb14d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_387a2058-2559-4e88-a71c-460eee04bf23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_9443567f-38a4-4f06-93e8-5f3a4de9d85a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b6e2e7e5-7cab-4ba7-ad95-85edf26918bd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_9443567f-38a4-4f06-93e8-5f3a4de9d85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c83786a5-6843-4455-ad33-ba4f11f3c87c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_9443567f-38a4-4f06-93e8-5f3a4de9d85a" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c83786a5-6843-4455-ad33-ba4f11f3c87c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5545dcb3-7caf-422f-8fde-8b0bb9f768a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_9443567f-38a4-4f06-93e8-5f3a4de9d85a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5545dcb3-7caf-422f-8fde-8b0bb9f768a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2b2a9e06-a660-4bb6-b056-b87228a9276f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b6e2e7e5-7cab-4ba7-ad95-85edf26918bd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2b2a9e06-a660-4bb6-b056-b87228a9276f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_NetProceedsFromIssuanceOfCommonStockAndWarrants_79dd7a40-7f8c-47ad-b2e4-f1e5c0482c7b" xlink:href="dare-20211231.xsd#dare_NetProceedsFromIssuanceOfCommonStockAndWarrants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2b2a9e06-a660-4bb6-b056-b87228a9276f" xlink:to="loc_dare_NetProceedsFromIssuanceOfCommonStockAndWarrants_79dd7a40-7f8c-47ad-b2e4-f1e5c0482c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_ProceedsFromIssuanceOfCommonStockAndWarrants_982c6ca0-a580-44a1-933f-3a01a2f8d0b5" xlink:href="dare-20211231.xsd#dare_ProceedsFromIssuanceOfCommonStockAndWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2b2a9e06-a660-4bb6-b056-b87228a9276f" xlink:to="loc_dare_ProceedsFromIssuanceOfCommonStockAndWarrants_982c6ca0-a580-44a1-933f-3a01a2f8d0b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_ba8e6310-f93b-417b-8012-d474ccfe3d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2b2a9e06-a660-4bb6-b056-b87228a9276f" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_ba8e6310-f93b-417b-8012-d474ccfe3d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_a7ca2903-cfc8-4326-a373-b80be2c9599c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2b2a9e06-a660-4bb6-b056-b87228a9276f" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_a7ca2903-cfc8-4326-a373-b80be2c9599c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f4e85f22-d713-4d56-8a95-f88a7171069c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2b2a9e06-a660-4bb6-b056-b87228a9276f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f4e85f22-d713-4d56-8a95-f88a7171069c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6d8bb2de-e9bb-422f-9f6f-54a5db7dcd61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b6e2e7e5-7cab-4ba7-ad95-85edf26918bd" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6d8bb2de-e9bb-422f-9f6f-54a5db7dcd61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ee52984d-5eda-4174-8989-8c26766f582a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b6e2e7e5-7cab-4ba7-ad95-85edf26918bd" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ee52984d-5eda-4174-8989-8c26766f582a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e45df6f3-3b47-446f-b3e4-dd3c84b41e08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b6e2e7e5-7cab-4ba7-ad95-85edf26918bd" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e45df6f3-3b47-446f-b3e4-dd3c84b41e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_041b6c86-4071-4b29-ad4a-6df95e299fda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b6e2e7e5-7cab-4ba7-ad95-85edf26918bd" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_041b6c86-4071-4b29-ad4a-6df95e299fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_8a43f99a-8d30-4868-a785-8f05b83b2139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b6e2e7e5-7cab-4ba7-ad95-85edf26918bd" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_8a43f99a-8d30-4868-a785-8f05b83b2139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_705c1b7f-d226-4c2f-a6e5-b0c1e5cc6c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_8a43f99a-8d30-4868-a785-8f05b83b2139" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_705c1b7f-d226-4c2f-a6e5-b0c1e5cc6c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_a26e773d-f30a-4d97-988c-e6c0baed63fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_8a43f99a-8d30-4868-a785-8f05b83b2139" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_a26e773d-f30a-4d97-988c-e6c0baed63fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_MilestonePaymentsContingentAmount_eaa1046a-45a4-4b0e-80cf-c3ee7278015e" xlink:href="dare-20211231.xsd#dare_MilestonePaymentsContingentAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_8a43f99a-8d30-4868-a785-8f05b83b2139" xlink:to="loc_dare_MilestonePaymentsContingentAmount_eaa1046a-45a4-4b0e-80cf-c3ee7278015e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_IssuanceCostOnEquityPaidInCommonStock_aaae9c9d-8445-4e85-aa12-5ee2c74e558a" xlink:href="dare-20211231.xsd#dare_IssuanceCostOnEquityPaidInCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_8a43f99a-8d30-4868-a785-8f05b83b2139" xlink:to="loc_dare_IssuanceCostOnEquityPaidInCommonStock_aaae9c9d-8445-4e85-aa12-5ee2c74e558a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_DeemedDividendFromTriggerOfRoundDownProvisionFeature_cdc08925-f130-4650-a455-a9c2f5d2b55d" xlink:href="dare-20211231.xsd#dare_DeemedDividendFromTriggerOfRoundDownProvisionFeature"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_8a43f99a-8d30-4868-a785-8f05b83b2139" xlink:to="loc_dare_DeemedDividendFromTriggerOfRoundDownProvisionFeature_cdc08925-f130-4650-a455-a9c2f5d2b55d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/OrganizationandDescriptionofBusiness" xlink:type="simple" xlink:href="dare-20211231.xsd#OrganizationandDescriptionofBusiness"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/OrganizationandDescriptionofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a77b139e-fb5f-4fb5-a682-b77010d1bbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_112d824c-8339-451f-b283-a408b2f06872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a77b139e-fb5f-4fb5-a682-b77010d1bbf9" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_112d824c-8339-451f-b283-a408b2f06872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/OrganizationandDescriptionofBusinessDetails" xlink:type="simple" xlink:href="dare-20211231.xsd#OrganizationandDescriptionofBusinessDetails"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/OrganizationandDescriptionofBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ab2dbe7e-8669-4fd0-94a7-c7d3e0629570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_c69242d5-9729-46be-99e4-2445fb06f86b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ab2dbe7e-8669-4fd0-94a7-c7d3e0629570" xlink:to="loc_us-gaap_NumberOfOperatingSegments_c69242d5-9729-46be-99e4-2445fb06f86b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="dare-20211231.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b879a8b3-f31a-48ff-939f-1c0bf9bfc269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_d65acf65-f990-46bc-b5fc-3c19c6cf0071" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b879a8b3-f31a-48ff-939f-1c0bf9bfc269" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_d65acf65-f990-46bc-b5fc-3c19c6cf0071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="dare-20211231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_56a278a1-c380-4dec-9cd0-853a46afdb48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0c05f674-7732-4bfa-a723-66aaae0f5837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56a278a1-c380-4dec-9cd0-853a46afdb48" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0c05f674-7732-4bfa-a723-66aaae0f5837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_LiquidityPolicyTextBlock_8c82d52f-9952-4429-821a-711892c1d3a4" xlink:href="dare-20211231.xsd#dare_LiquidityPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56a278a1-c380-4dec-9cd0-853a46afdb48" xlink:to="loc_dare_LiquidityPolicyTextBlock_8c82d52f-9952-4429-821a-711892c1d3a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_05163a04-372b-45dd-b980-7221a5f74ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56a278a1-c380-4dec-9cd0-853a46afdb48" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_05163a04-372b-45dd-b980-7221a5f74ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_a86e1e37-a689-41fe-8eb7-fd375b05aed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56a278a1-c380-4dec-9cd0-853a46afdb48" xlink:to="loc_us-gaap_UseOfEstimates_a86e1e37-a689-41fe-8eb7-fd375b05aed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_RisksAndUncertaintiesPolicyTextBlock_2be199c2-8ed0-4c91-9d28-5a1ab31e0f79" xlink:href="dare-20211231.xsd#dare_RisksAndUncertaintiesPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56a278a1-c380-4dec-9cd0-853a46afdb48" xlink:to="loc_dare_RisksAndUncertaintiesPolicyTextBlock_2be199c2-8ed0-4c91-9d28-5a1ab31e0f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_6cca2536-9c10-4ee9-a23d-02e0384b47df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56a278a1-c380-4dec-9cd0-853a46afdb48" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_6cca2536-9c10-4ee9-a23d-02e0384b47df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_875e0c7b-845a-487a-9b6d-285bcc41ddb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56a278a1-c380-4dec-9cd0-853a46afdb48" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_875e0c7b-845a-487a-9b6d-285bcc41ddb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_5f692d01-b7a1-4192-9328-7b11bd819381" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56a278a1-c380-4dec-9cd0-853a46afdb48" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_5f692d01-b7a1-4192-9328-7b11bd819381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_cfdc78fe-9e3f-45f3-80b8-d9b31fb0d132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56a278a1-c380-4dec-9cd0-853a46afdb48" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_cfdc78fe-9e3f-45f3-80b8-d9b31fb0d132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_0935181e-9112-46e1-a04a-bd59a2c2d402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56a278a1-c380-4dec-9cd0-853a46afdb48" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_0935181e-9112-46e1-a04a-bd59a2c2d402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_36cbf496-7989-42d9-b966-1ceebdfb78de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56a278a1-c380-4dec-9cd0-853a46afdb48" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_36cbf496-7989-42d9-b966-1ceebdfb78de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_98af26f2-97b4-4fc6-9e9f-3f7aeeb47d89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56a278a1-c380-4dec-9cd0-853a46afdb48" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_98af26f2-97b4-4fc6-9e9f-3f7aeeb47d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_325ba5bd-4340-4916-89c9-a307b55787c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56a278a1-c380-4dec-9cd0-853a46afdb48" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_325ba5bd-4340-4916-89c9-a307b55787c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_f158ce4b-72fa-4024-a951-dd1df3e977ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56a278a1-c380-4dec-9cd0-853a46afdb48" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_f158ce4b-72fa-4024-a951-dd1df3e977ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_eaad3339-e918-433d-8dc7-115d7b27206a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56a278a1-c380-4dec-9cd0-853a46afdb48" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_eaad3339-e918-433d-8dc7-115d7b27206a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_e1546c63-02e6-423f-86b0-ad1eaa2d58ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56a278a1-c380-4dec-9cd0-853a46afdb48" xlink:to="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_e1546c63-02e6-423f-86b0-ad1eaa2d58ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="dare-20211231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_adbcba22-de6e-47ce-be96-8bc85d1eeb22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_133023ad-63f4-4627-b3da-ed886d0c7aed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_adbcba22-de6e-47ce-be96-8bc85d1eeb22" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_133023ad-63f4-4627-b3da-ed886d0c7aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" xlink:href="dare-20211231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a262bb5e-cf81-4c3d-9f7e-609468387814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_SignificantAccountingPoliciesTable_dd76fbcf-f9ca-4333-aa9b-573441a65d5e" xlink:href="dare-20211231.xsd#dare_SignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a262bb5e-cf81-4c3d-9f7e-609468387814" xlink:to="loc_dare_SignificantAccountingPoliciesTable_dd76fbcf-f9ca-4333-aa9b-573441a65d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_382a960b-aadd-427e-9046-c1594b8b35dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesTable_dd76fbcf-f9ca-4333-aa9b-573441a65d5e" xlink:to="loc_us-gaap_PlanNameAxis_382a960b-aadd-427e-9046-c1594b8b35dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_14388c15-2a65-487c-a16e-e5eabf2f4883" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_382a960b-aadd-427e-9046-c1594b8b35dd" xlink:to="loc_us-gaap_PlanNameDomain_14388c15-2a65-487c-a16e-e5eabf2f4883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_AmendedAndRestatedTwoThousandFourteenStockIncentivePlanMember_5c281d37-7879-4cce-8650-0e38e120bab1" xlink:href="dare-20211231.xsd#dare_AmendedAndRestatedTwoThousandFourteenStockIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_14388c15-2a65-487c-a16e-e5eabf2f4883" xlink:to="loc_dare_AmendedAndRestatedTwoThousandFourteenStockIncentivePlanMember_5c281d37-7879-4cce-8650-0e38e120bab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2bf5a27a-8bf6-44fd-a9ca-5e30edd42638" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesTable_dd76fbcf-f9ca-4333-aa9b-573441a65d5e" xlink:to="loc_us-gaap_AwardTypeAxis_2bf5a27a-8bf6-44fd-a9ca-5e30edd42638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3c032b7b-f281-40c3-b62b-ef37de26a6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2bf5a27a-8bf6-44fd-a9ca-5e30edd42638" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3c032b7b-f281-40c3-b62b-ef37de26a6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_928c2f9e-6c6d-4d5b-b258-0c8ba6d2af51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3c032b7b-f281-40c3-b62b-ef37de26a6d7" xlink:to="loc_us-gaap_EmployeeStockOptionMember_928c2f9e-6c6d-4d5b-b258-0c8ba6d2af51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_ExerciseOfWarrantsOutstandingMember_02624b42-a1f6-4995-8a69-8c5e2039018c" xlink:href="dare-20211231.xsd#dare_ExerciseOfWarrantsOutstandingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3c032b7b-f281-40c3-b62b-ef37de26a6d7" xlink:to="loc_dare_ExerciseOfWarrantsOutstandingMember_02624b42-a1f6-4995-8a69-8c5e2039018c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_73efe237-8723-4d7a-ad13-4f49100cbd26" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesTable_dd76fbcf-f9ca-4333-aa9b-573441a65d5e" xlink:to="loc_srt_RangeAxis_73efe237-8723-4d7a-ad13-4f49100cbd26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_270b18aa-4b73-417f-bf5c-949972779150" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_73efe237-8723-4d7a-ad13-4f49100cbd26" xlink:to="loc_srt_RangeMember_270b18aa-4b73-417f-bf5c-949972779150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6b6edf34-c351-4eda-acc3-bce73c118ee6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_270b18aa-4b73-417f-bf5c-949972779150" xlink:to="loc_srt_MinimumMember_6b6edf34-c351-4eda-acc3-bce73c118ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f472560a-48fc-450b-8c1b-d8a18461e9c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesTable_dd76fbcf-f9ca-4333-aa9b-573441a65d5e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f472560a-48fc-450b-8c1b-d8a18461e9c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1ee33b7d-2891-4ae3-ab7d-7abf3303a0bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f472560a-48fc-450b-8c1b-d8a18461e9c1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1ee33b7d-2891-4ae3-ab7d-7abf3303a0bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4b2a8439-4c90-4ad8-8bc0-f5dab9bd493b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1ee33b7d-2891-4ae3-ab7d-7abf3303a0bf" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4b2a8439-4c90-4ad8-8bc0-f5dab9bd493b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_646b35e9-9387-4ff8-8454-f94b81bff867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesTable_dd76fbcf-f9ca-4333-aa9b-573441a65d5e" xlink:to="loc_us-gaap_TypeOfArrangementAxis_646b35e9-9387-4ff8-8454-f94b81bff867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d4e3c26d-fe45-48ef-a78c-538ca2c335b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_646b35e9-9387-4ff8-8454-f94b81bff867" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d4e3c26d-fe45-48ef-a78c-538ca2c335b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_BayerHealthcareLicenseAgreementMember_bd16122c-8fdc-42ea-97cf-4940aebb3de1" xlink:href="dare-20211231.xsd#dare_BayerHealthcareLicenseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d4e3c26d-fe45-48ef-a78c-538ca2c335b1" xlink:to="loc_dare_BayerHealthcareLicenseAgreementMember_bd16122c-8fdc-42ea-97cf-4940aebb3de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_299a30e9-d219-49d9-b49c-b4e8b0e8612d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesTable_dd76fbcf-f9ca-4333-aa9b-573441a65d5e" xlink:to="loc_srt_CounterpartyNameAxis_299a30e9-d219-49d9-b49c-b4e8b0e8612d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_dc5e2a18-cf8f-468d-a799-e9f8fc5a6e74" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_299a30e9-d219-49d9-b49c-b4e8b0e8612d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_dc5e2a18-cf8f-468d-a799-e9f8fc5a6e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_OrganonMember_019b1f23-d50f-4030-b08b-645958a378f5" xlink:href="dare-20211231.xsd#dare_OrganonMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_dc5e2a18-cf8f-468d-a799-e9f8fc5a6e74" xlink:to="loc_dare_OrganonMember_019b1f23-d50f-4030-b08b-645958a378f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_SignificantAccountingPoliciesLineItems_8e5891ac-421d-4a2a-be71-13a3eba4fdff" xlink:href="dare-20211231.xsd#dare_SignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesTable_dd76fbcf-f9ca-4333-aa9b-573441a65d5e" xlink:to="loc_dare_SignificantAccountingPoliciesLineItems_8e5891ac-421d-4a2a-be71-13a3eba4fdff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a61e017e-3766-4199-afe1-3d8e98ed08a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_8e5891ac-421d-4a2a-be71-13a3eba4fdff" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a61e017e-3766-4199-afe1-3d8e98ed08a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt_c8f8fcc5-ac0b-4a00-bd9f-e67f6d8d0b82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_8e5891ac-421d-4a2a-be71-13a3eba4fdff" xlink:to="loc_us-gaap_ConvertibleDebt_c8f8fcc5-ac0b-4a00-bd9f-e67f6d8d0b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_WorkingCapitalIncreaseDeficit_0de0d1ee-8e79-4572-8711-e6e4ce93a14f" xlink:href="dare-20211231.xsd#dare_WorkingCapitalIncreaseDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_8e5891ac-421d-4a2a-be71-13a3eba4fdff" xlink:to="loc_dare_WorkingCapitalIncreaseDeficit_0de0d1ee-8e79-4572-8711-e6e4ce93a14f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6032427d-18c9-4602-855d-d6d3ae167de6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_8e5891ac-421d-4a2a-be71-13a3eba4fdff" xlink:to="loc_us-gaap_NetIncomeLoss_6032427d-18c9-4602-855d-d6d3ae167de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_ad11d901-d87c-4c84-9b27-aa2bf3c62251" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_8e5891ac-421d-4a2a-be71-13a3eba4fdff" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_ad11d901-d87c-4c84-9b27-aa2bf3c62251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_MilestonePaymentsContingentAmount_e8978547-e040-4ebb-9ff8-c8622ab4dc52" xlink:href="dare-20211231.xsd#dare_MilestonePaymentsContingentAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_8e5891ac-421d-4a2a-be71-13a3eba4fdff" xlink:to="loc_dare_MilestonePaymentsContingentAmount_e8978547-e040-4ebb-9ff8-c8622ab4dc52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_UpfrontLicenseFeeAmountPaid_ab380ebf-55c0-41df-9ff1-81310488b89a" xlink:href="dare-20211231.xsd#dare_UpfrontLicenseFeeAmountPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_8e5891ac-421d-4a2a-be71-13a3eba4fdff" xlink:to="loc_dare_UpfrontLicenseFeeAmountPaid_ab380ebf-55c0-41df-9ff1-81310488b89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_MilestonePaymentsContingentAmountFirstCommercialSaleAmount_3a1c5441-42a4-4acf-9c1e-c323bc354055" xlink:href="dare-20211231.xsd#dare_MilestonePaymentsContingentAmountFirstCommercialSaleAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_8e5891ac-421d-4a2a-be71-13a3eba4fdff" xlink:to="loc_dare_MilestonePaymentsContingentAmountFirstCommercialSaleAmount_3a1c5441-42a4-4acf-9c1e-c323bc354055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_MilestonePaymentsContingentAmountSalesBasedMilestonesAmount_0eb45830-93ee-4129-aa29-27635556b20a" xlink:href="dare-20211231.xsd#dare_MilestonePaymentsContingentAmountSalesBasedMilestonesAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_8e5891ac-421d-4a2a-be71-13a3eba4fdff" xlink:to="loc_dare_MilestonePaymentsContingentAmountSalesBasedMilestonesAmount_0eb45830-93ee-4129-aa29-27635556b20a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_PeriodofInsufficientCashandLiquidityRequirements_a2ef5a2e-6059-4e86-a895-68fc3f2835ee" xlink:href="dare-20211231.xsd#dare_PeriodofInsufficientCashandLiquidityRequirements"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_8e5891ac-421d-4a2a-be71-13a3eba4fdff" xlink:to="loc_dare_PeriodofInsufficientCashandLiquidityRequirements_a2ef5a2e-6059-4e86-a895-68fc3f2835ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_GrantFundingRecognizedDuringPeriod_cd08f275-b3f8-4746-b252-3d5df7186314" xlink:href="dare-20211231.xsd#dare_GrantFundingRecognizedDuringPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_8e5891ac-421d-4a2a-be71-13a3eba4fdff" xlink:to="loc_dare_GrantFundingRecognizedDuringPeriod_cd08f275-b3f8-4746-b252-3d5df7186314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_ba725db2-f14d-4f1d-a2a4-923844f5c7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_8e5891ac-421d-4a2a-be71-13a3eba4fdff" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_ba725db2-f14d-4f1d-a2a4-923844f5c7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFDICInsuredAmount_057af4ac-3828-4233-a6f0-e1b66a836065" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFDICInsuredAmount"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_8e5891ac-421d-4a2a-be71-13a3eba4fdff" xlink:to="loc_us-gaap_CashFDICInsuredAmount_057af4ac-3828-4233-a6f0-e1b66a836065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b8fbc552-0969-4de3-a2a0-a1b0353359c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_8e5891ac-421d-4a2a-be71-13a3eba4fdff" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b8fbc552-0969-4de3-a2a0-a1b0353359c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_f3e97eb4-8071-40ad-95d8-ff2a84a79731" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_8e5891ac-421d-4a2a-be71-13a3eba4fdff" xlink:to="loc_us-gaap_NumberOfOperatingSegments_f3e97eb4-8071-40ad-95d8-ff2a84a79731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_85560c9c-0737-416e-976a-f386f413f1cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_8e5891ac-421d-4a2a-be71-13a3eba4fdff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_85560c9c-0737-416e-976a-f386f413f1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_234228b0-9c5a-4750-922a-73ad08a48ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_8e5891ac-421d-4a2a-be71-13a3eba4fdff" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_234228b0-9c5a-4750-922a-73ad08a48ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_cf8dd9e4-76ac-47ac-a09b-57ecc4bd4824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_8e5891ac-421d-4a2a-be71-13a3eba4fdff" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_cf8dd9e4-76ac-47ac-a09b-57ecc4bd4824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_1cc39584-8ea9-4ff7-b8f9-a6d2230121b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_8e5891ac-421d-4a2a-be71-13a3eba4fdff" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_1cc39584-8ea9-4ff7-b8f9-a6d2230121b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_AccruedIndemnificationProvisions_744fe617-956d-4f44-a4bd-34ac402b8a7d" xlink:href="dare-20211231.xsd#dare_AccruedIndemnificationProvisions"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_8e5891ac-421d-4a2a-be71-13a3eba4fdff" xlink:to="loc_dare_AccruedIndemnificationProvisions_744fe617-956d-4f44-a4bd-34ac402b8a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFinancialAssetsandLiabilitiesRemeasuredonaRecurringBasisLevel2Details" xlink:type="simple" xlink:href="dare-20211231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesFinancialAssetsandLiabilitiesRemeasuredonaRecurringBasisLevel2Details"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFinancialAssetsandLiabilitiesRemeasuredonaRecurringBasisLevel2Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_14fd7ffc-84fb-4312-a5ed-02ca6b2a5eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_SignificantAccountingPoliciesTable_40f70890-ad55-4e5d-b69f-3805d62b715f" xlink:href="dare-20211231.xsd#dare_SignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_14fd7ffc-84fb-4312-a5ed-02ca6b2a5eb1" xlink:to="loc_dare_SignificantAccountingPoliciesTable_40f70890-ad55-4e5d-b69f-3805d62b715f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7fe95d4e-b32d-4eee-a66b-67aaaaf0ae9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesTable_40f70890-ad55-4e5d-b69f-3805d62b715f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7fe95d4e-b32d-4eee-a66b-67aaaaf0ae9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b5e0289b-5439-45f7-95af-60b5c9112d23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7fe95d4e-b32d-4eee-a66b-67aaaaf0ae9c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b5e0289b-5439-45f7-95af-60b5c9112d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_2dbe90b7-dfc0-4c96-8f3c-8a75e32944c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b5e0289b-5439-45f7-95af-60b5c9112d23" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_2dbe90b7-dfc0-4c96-8f3c-8a75e32944c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1a37a21e-c631-4b4e-8d5a-87f644defcb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b5e0289b-5439-45f7-95af-60b5c9112d23" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1a37a21e-c631-4b4e-8d5a-87f644defcb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_45b83d5a-88f5-4332-bbab-da6f931f2c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b5e0289b-5439-45f7-95af-60b5c9112d23" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_45b83d5a-88f5-4332-bbab-da6f931f2c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_79391768-ece0-4bba-94a5-6c9b74bd4530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesTable_40f70890-ad55-4e5d-b69f-3805d62b715f" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_79391768-ece0-4bba-94a5-6c9b74bd4530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ebe7708-4023-4634-9f33-80fa9e2312c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_79391768-ece0-4bba-94a5-6c9b74bd4530" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ebe7708-4023-4634-9f33-80fa9e2312c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_8bf96f57-ceb3-4289-bfd9-4abb449d0fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ebe7708-4023-4634-9f33-80fa9e2312c3" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_8bf96f57-ceb3-4289-bfd9-4abb449d0fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_SignificantAccountingPoliciesLineItems_e4a9c5c9-67d3-49e8-a2c1-53940edd4a92" xlink:href="dare-20211231.xsd#dare_SignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesTable_40f70890-ad55-4e5d-b69f-3805d62b715f" xlink:to="loc_dare_SignificantAccountingPoliciesLineItems_e4a9c5c9-67d3-49e8-a2c1-53940edd4a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_2edffa45-57d2-4531-bf4c-144413cffec8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_e4a9c5c9-67d3-49e8-a2c1-53940edd4a92" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_2edffa45-57d2-4531-bf4c-144413cffec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_AssetAcquisitionContingentConsiderationNoncurrent_1293f93f-90f9-48ef-a9b4-deda840233c5" xlink:href="dare-20211231.xsd#dare_AssetAcquisitionContingentConsiderationNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_e4a9c5c9-67d3-49e8-a2c1-53940edd4a92" xlink:to="loc_dare_AssetAcquisitionContingentConsiderationNoncurrent_1293f93f-90f9-48ef-a9b4-deda840233c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFinancialAssetsandLiabilitiesRemeasuredonaRecurringBasisLevel3Details" xlink:type="simple" xlink:href="dare-20211231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesFinancialAssetsandLiabilitiesRemeasuredonaRecurringBasisLevel3Details"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFinancialAssetsandLiabilitiesRemeasuredonaRecurringBasisLevel3Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b31a9ebc-10bb-4715-9008-7f389c51ab57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_SignificantAccountingPoliciesTable_02d5a406-cc57-4a95-b37b-78c2fb4b2938" xlink:href="dare-20211231.xsd#dare_SignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b31a9ebc-10bb-4715-9008-7f389c51ab57" xlink:to="loc_dare_SignificantAccountingPoliciesTable_02d5a406-cc57-4a95-b37b-78c2fb4b2938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f3c366f3-a95f-403b-8c88-112161e3e502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesTable_02d5a406-cc57-4a95-b37b-78c2fb4b2938" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f3c366f3-a95f-403b-8c88-112161e3e502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e1bf70ea-c5dc-439b-a56d-aa6d9d1178d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f3c366f3-a95f-403b-8c88-112161e3e502" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e1bf70ea-c5dc-439b-a56d-aa6d9d1178d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d3964862-f5a8-46db-bc16-d388c804e1ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e1bf70ea-c5dc-439b-a56d-aa6d9d1178d8" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d3964862-f5a8-46db-bc16-d388c804e1ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_16a2816c-d7d8-4a60-8d68-2e6b49765af4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesTable_02d5a406-cc57-4a95-b37b-78c2fb4b2938" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_16a2816c-d7d8-4a60-8d68-2e6b49765af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_be70b319-91b5-4fa2-bc31-c26016bedcac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_16a2816c-d7d8-4a60-8d68-2e6b49765af4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_be70b319-91b5-4fa2-bc31-c26016bedcac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_MicrochipsBiotechInc.Member_537566b2-a45b-4b50-bc7b-a737af379cf1" xlink:href="dare-20211231.xsd#dare_MicrochipsBiotechInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_be70b319-91b5-4fa2-bc31-c26016bedcac" xlink:to="loc_dare_MicrochipsBiotechInc.Member_537566b2-a45b-4b50-bc7b-a737af379cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_SignificantAccountingPoliciesLineItems_e54faddd-de28-48e1-b509-6f6e8b7eda85" xlink:href="dare-20211231.xsd#dare_SignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesTable_02d5a406-cc57-4a95-b37b-78c2fb4b2938" xlink:to="loc_dare_SignificantAccountingPoliciesLineItems_e54faddd-de28-48e1-b509-6f6e8b7eda85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_AssetAcquisitionContingentConsiderationRollforwardAbstract_79bedf6d-7208-419d-a8c6-8b2004aff95a" xlink:href="dare-20211231.xsd#dare_AssetAcquisitionContingentConsiderationRollforwardAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_e54faddd-de28-48e1-b509-6f6e8b7eda85" xlink:to="loc_dare_AssetAcquisitionContingentConsiderationRollforwardAbstract_79bedf6d-7208-419d-a8c6-8b2004aff95a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_AssetAcquisitionContingentConsideration_3849d36a-0b12-466a-b107-1fed047d908b" xlink:href="dare-20211231.xsd#dare_AssetAcquisitionContingentConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_AssetAcquisitionContingentConsiderationRollforwardAbstract_79bedf6d-7208-419d-a8c6-8b2004aff95a" xlink:to="loc_dare_AssetAcquisitionContingentConsideration_3849d36a-0b12-466a-b107-1fed047d908b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_20b11662-b1ae-492c-97c3-788bd86ac8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_AssetAcquisitionContingentConsiderationRollforwardAbstract_79bedf6d-7208-419d-a8c6-8b2004aff95a" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_20b11662-b1ae-492c-97c3-788bd86ac8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_AssetAcquisitionContingentConsideration_d6fc01d8-72cb-4d0c-bd38-df92cb06c326" xlink:href="dare-20211231.xsd#dare_AssetAcquisitionContingentConsideration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_AssetAcquisitionContingentConsiderationRollforwardAbstract_79bedf6d-7208-419d-a8c6-8b2004aff95a" xlink:to="loc_dare_AssetAcquisitionContingentConsideration_d6fc01d8-72cb-4d0c-bd38-df92cb06c326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_103bccd1-4fa7-4ef7-b2d1-0b1544674ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_e54faddd-de28-48e1-b509-6f6e8b7eda85" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_103bccd1-4fa7-4ef7-b2d1-0b1544674ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/StrategicAgreements" xlink:type="simple" xlink:href="dare-20211231.xsd#StrategicAgreements"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StrategicAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1bab8659-9706-4264-a712-f187a1545e99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_b5e715e0-76fc-4fe7-91d8-a4f3acab39f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1bab8659-9706-4264-a712-f187a1545e99" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_b5e715e0-76fc-4fe7-91d8-a4f3acab39f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/StrategicAgreementsAdditionalInformationDetails" xlink:type="simple" xlink:href="dare-20211231.xsd#StrategicAgreementsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StrategicAgreementsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9546a38a-fc95-4618-89c2-a89416ff1fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7024ac2a-d972-4a8b-aeec-3f36b55af2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9546a38a-fc95-4618-89c2-a89416ff1fe0" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7024ac2a-d972-4a8b-aeec-3f36b55af2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_8312b70d-3e24-4c8f-a40b-138c21e49813" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7024ac2a-d972-4a8b-aeec-3f36b55af2c8" xlink:to="loc_us-gaap_TypeOfArrangementAxis_8312b70d-3e24-4c8f-a40b-138c21e49813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_10039ad6-5634-4df9-b9b3-3968a71a653d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_8312b70d-3e24-4c8f-a40b-138c21e49813" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_10039ad6-5634-4df9-b9b3-3968a71a653d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_BayerHealthcareLicenseAgreementMember_af6d4e9b-5e0c-46e4-abea-8aea414d4084" xlink:href="dare-20211231.xsd#dare_BayerHealthcareLicenseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_10039ad6-5634-4df9-b9b3-3968a71a653d" xlink:to="loc_dare_BayerHealthcareLicenseAgreementMember_af6d4e9b-5e0c-46e4-abea-8aea414d4084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_b6912a4d-5697-409a-b7cd-387b128f84b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_10039ad6-5634-4df9-b9b3-3968a71a653d" xlink:to="loc_us-gaap_LicensingAgreementsMember_b6912a4d-5697-409a-b7cd-387b128f84b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_AssignmentAgreementMember_942bf3a9-8740-4099-a08b-280b8c288dfa" xlink:href="dare-20211231.xsd#dare_AssignmentAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_10039ad6-5634-4df9-b9b3-3968a71a653d" xlink:to="loc_dare_AssignmentAgreementMember_942bf3a9-8740-4099-a08b-280b8c288dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_LicenseAndCollaborationAgreementMember_198a61f3-28b1-4532-b7b3-4bb731ff9ef3" xlink:href="dare-20211231.xsd#dare_LicenseAndCollaborationAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_10039ad6-5634-4df9-b9b3-3968a71a653d" xlink:to="loc_dare_LicenseAndCollaborationAgreementMember_198a61f3-28b1-4532-b7b3-4bb731ff9ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_JuniperPharmaceuticalsInc.Member_43f1a415-1301-4149-8550-b6b24db05701" xlink:href="dare-20211231.xsd#dare_JuniperPharmaceuticalsInc.Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_10039ad6-5634-4df9-b9b3-3968a71a653d" xlink:to="loc_dare_JuniperPharmaceuticalsInc.Member_43f1a415-1301-4149-8550-b6b24db05701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_1379ff32-8535-4162-9ffd-1229ab48e951" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7024ac2a-d972-4a8b-aeec-3f36b55af2c8" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_1379ff32-8535-4162-9ffd-1229ab48e951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_11025c89-26e2-4581-b5bf-c45af13961c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_1379ff32-8535-4162-9ffd-1229ab48e951" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_11025c89-26e2-4581-b5bf-c45af13961c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_UponAchievingCertainDevelopmentMilestonesMember_90812e94-26a9-4d38-bcb2-94eba0523e72" xlink:href="dare-20211231.xsd#dare_UponAchievingCertainDevelopmentMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_11025c89-26e2-4581-b5bf-c45af13961c7" xlink:to="loc_dare_UponAchievingCertainDevelopmentMilestonesMember_90812e94-26a9-4d38-bcb2-94eba0523e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_UponAchievingCertainCommercialMilestonesMember_22608dc8-9c90-4f4c-9565-e1417d1b6db9" xlink:href="dare-20211231.xsd#dare_UponAchievingCertainCommercialMilestonesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_11025c89-26e2-4581-b5bf-c45af13961c7" xlink:to="loc_dare_UponAchievingCertainCommercialMilestonesMember_22608dc8-9c90-4f4c-9565-e1417d1b6db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_UponAchievingCertainClinicalAndRegulatoryDevelopmentMilestonesMember_392211d7-1614-4524-b55f-a7c342a80fcf" xlink:href="dare-20211231.xsd#dare_UponAchievingCertainClinicalAndRegulatoryDevelopmentMilestonesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_11025c89-26e2-4581-b5bf-c45af13961c7" xlink:to="loc_dare_UponAchievingCertainClinicalAndRegulatoryDevelopmentMilestonesMember_392211d7-1614-4524-b55f-a7c342a80fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_98ef96d8-f7f4-4a8b-b500-9a440f3ec292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7024ac2a-d972-4a8b-aeec-3f36b55af2c8" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_98ef96d8-f7f4-4a8b-b500-9a440f3ec292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_3259c85b-4625-4f72-b3b4-bd59a52b5a38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_98ef96d8-f7f4-4a8b-b500-9a440f3ec292" xlink:to="loc_us-gaap_RelatedPartyDomain_3259c85b-4625-4f72-b3b4-bd59a52b5a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_MilanaPharmMember_213338d1-8d4c-49ef-8469-49b09ea4166f" xlink:href="dare-20211231.xsd#dare_MilanaPharmMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3259c85b-4625-4f72-b3b4-bd59a52b5a38" xlink:to="loc_dare_MilanaPharmMember_213338d1-8d4c-49ef-8469-49b09ea4166f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_HammockPharmaceuticalsInc.Member_7e71e048-102a-4ff1-af2a-62eb91530018" xlink:href="dare-20211231.xsd#dare_HammockPharmaceuticalsInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3259c85b-4625-4f72-b3b4-bd59a52b5a38" xlink:to="loc_dare_HammockPharmaceuticalsInc.Member_7e71e048-102a-4ff1-af2a-62eb91530018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_StrategicScienceAndTechnologiesDLimitedLiabilityCompanyAndStrategicScienceTechnologiesLimitedLiabilityCompanyMember_27578507-c3cf-4dea-ab86-bc2775613c96" xlink:href="dare-20211231.xsd#dare_StrategicScienceAndTechnologiesDLimitedLiabilityCompanyAndStrategicScienceTechnologiesLimitedLiabilityCompanyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3259c85b-4625-4f72-b3b4-bd59a52b5a38" xlink:to="loc_dare_StrategicScienceAndTechnologiesDLimitedLiabilityCompanyAndStrategicScienceTechnologiesLimitedLiabilityCompanyMember_27578507-c3cf-4dea-ab86-bc2775613c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_904431f7-0f7a-4281-b82d-fbb5801bebf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7024ac2a-d972-4a8b-aeec-3f36b55af2c8" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_904431f7-0f7a-4281-b82d-fbb5801bebf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_fa5d6ec1-9851-48d4-969a-a43978de2ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_904431f7-0f7a-4281-b82d-fbb5801bebf2" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_fa5d6ec1-9851-48d4-969a-a43978de2ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_ADVATecAgreementMember_6260f7b6-e284-475d-86b0-35a731642b00" xlink:href="dare-20211231.xsd#dare_ADVATecAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_fa5d6ec1-9851-48d4-969a-a43978de2ce3" xlink:to="loc_dare_ADVATecAgreementMember_6260f7b6-e284-475d-86b0-35a731642b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_ClinicalAndRegulatoryMilestonesMember_15746657-088e-486f-afde-732020d5d88a" xlink:href="dare-20211231.xsd#dare_ClinicalAndRegulatoryMilestonesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_fa5d6ec1-9851-48d4-969a-a43978de2ce3" xlink:to="loc_dare_ClinicalAndRegulatoryMilestonesMember_15746657-088e-486f-afde-732020d5d88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_SalesMilestonesMember_a0c5d032-671e-4685-8996-d1aee8e9bc7a" xlink:href="dare-20211231.xsd#dare_SalesMilestonesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_fa5d6ec1-9851-48d4-969a-a43978de2ce3" xlink:to="loc_dare_SalesMilestonesMember_a0c5d032-671e-4685-8996-d1aee8e9bc7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_51217bda-d587-4111-b919-1a308b0c36b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7024ac2a-d972-4a8b-aeec-3f36b55af2c8" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_51217bda-d587-4111-b919-1a308b0c36b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_2a20e687-0e34-43f5-a63a-029300165653" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_51217bda-d587-4111-b919-1a308b0c36b7" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_2a20e687-0e34-43f5-a63a-029300165653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_UponAchievementOfSpecifiedDevelopmentAndRegulatoryMilestonesMember_2aca6a1a-785c-4931-9415-3438bfeaa6f5" xlink:href="dare-20211231.xsd#dare_UponAchievementOfSpecifiedDevelopmentAndRegulatoryMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_2a20e687-0e34-43f5-a63a-029300165653" xlink:to="loc_dare_UponAchievementOfSpecifiedDevelopmentAndRegulatoryMilestonesMember_2aca6a1a-785c-4931-9415-3438bfeaa6f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_ea8d9030-f114-430e-b4f2-84d6f5ee5cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7024ac2a-d972-4a8b-aeec-3f36b55af2c8" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_ea8d9030-f114-430e-b4f2-84d6f5ee5cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_0dd56eac-0597-4eb0-a9d0-eb7dc85be3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProjectMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_ea8d9030-f114-430e-b4f2-84d6f5ee5cdd" xlink:to="loc_us-gaap_ProjectMember_0dd56eac-0597-4eb0-a9d0-eb7dc85be3bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_UponAchievementOfSpecifiedDevelopmentAndRegulatoryMilestonesMember_ec23e8eb-a6e5-4a1d-bfa1-f497f7d940b2" xlink:href="dare-20211231.xsd#dare_UponAchievementOfSpecifiedDevelopmentAndRegulatoryMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_0dd56eac-0597-4eb0-a9d0-eb7dc85be3bf" xlink:to="loc_dare_UponAchievementOfSpecifiedDevelopmentAndRegulatoryMilestonesMember_ec23e8eb-a6e5-4a1d-bfa1-f497f7d940b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_UponReachingCertainWorldwideNetSalesMilestonesMember_9de834b1-432f-4139-8ae1-d59a92fe706e" xlink:href="dare-20211231.xsd#dare_UponReachingCertainWorldwideNetSalesMilestonesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_0dd56eac-0597-4eb0-a9d0-eb7dc85be3bf" xlink:to="loc_dare_UponReachingCertainWorldwideNetSalesMilestonesMember_9de834b1-432f-4139-8ae1-d59a92fe706e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3b1fcf69-a955-403e-b4e4-4db532f5d582" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7024ac2a-d972-4a8b-aeec-3f36b55af2c8" xlink:to="loc_srt_RangeAxis_3b1fcf69-a955-403e-b4e4-4db532f5d582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6e0d401f-0d2d-4a5f-9279-34362f63f19a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3b1fcf69-a955-403e-b4e4-4db532f5d582" xlink:to="loc_srt_RangeMember_6e0d401f-0d2d-4a5f-9279-34362f63f19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_dcedf6ca-b758-4a0b-ada1-84d89e22c5a7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6e0d401f-0d2d-4a5f-9279-34362f63f19a" xlink:to="loc_srt_MaximumMember_dcedf6ca-b758-4a0b-ada1-84d89e22c5a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f776f337-09fd-44fe-95a8-d13a0a230082" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6e0d401f-0d2d-4a5f-9279-34362f63f19a" xlink:to="loc_srt_MinimumMember_f776f337-09fd-44fe-95a8-d13a0a230082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_935ea62b-ea22-4849-9c58-de88f0389389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7024ac2a-d972-4a8b-aeec-3f36b55af2c8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_935ea62b-ea22-4849-9c58-de88f0389389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9445905a-115e-4292-8c67-45ee835e655b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_935ea62b-ea22-4849-9c58-de88f0389389" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9445905a-115e-4292-8c67-45ee835e655b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_MicrochipsBiotechInc.Member_819b59c0-0a9f-45f7-98bd-8ee3fc87e0b1" xlink:href="dare-20211231.xsd#dare_MicrochipsBiotechInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9445905a-115e-4292-8c67-45ee835e655b" xlink:to="loc_dare_MicrochipsBiotechInc.Member_819b59c0-0a9f-45f7-98bd-8ee3fc87e0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_8d9785fd-f6e5-425f-a2ad-972f3125f5ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7024ac2a-d972-4a8b-aeec-3f36b55af2c8" xlink:to="loc_us-gaap_StatementClassOfStockAxis_8d9785fd-f6e5-425f-a2ad-972f3125f5ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_be1d55fd-10cd-4ab8-a3fc-f839ffc5f2a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_8d9785fd-f6e5-425f-a2ad-972f3125f5ec" xlink:to="loc_us-gaap_ClassOfStockDomain_be1d55fd-10cd-4ab8-a3fc-f839ffc5f2a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7149f698-3980-4c81-bd16-8f77b45a1f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_be1d55fd-10cd-4ab8-a3fc-f839ffc5f2a6" xlink:to="loc_us-gaap_CommonStockMember_7149f698-3980-4c81-bd16-8f77b45a1f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_41c8ff2f-64cd-460d-90e8-5c5c43f52050" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7024ac2a-d972-4a8b-aeec-3f36b55af2c8" xlink:to="loc_srt_CounterpartyNameAxis_41c8ff2f-64cd-460d-90e8-5c5c43f52050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_79cdcf81-d353-45b8-a247-731be6f4c0bb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_41c8ff2f-64cd-460d-90e8-5c5c43f52050" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_79cdcf81-d353-45b8-a247-731be6f4c0bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_CatalentAndMilanaPharmMember_789a1b1c-0da8-4f66-986c-127bd81e415a" xlink:href="dare-20211231.xsd#dare_CatalentAndMilanaPharmMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_79cdcf81-d353-45b8-a247-731be6f4c0bb" xlink:to="loc_dare_CatalentAndMilanaPharmMember_789a1b1c-0da8-4f66-986c-127bd81e415a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7ecc48cf-c2aa-45ee-8245-b122888aec05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7024ac2a-d972-4a8b-aeec-3f36b55af2c8" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7ecc48cf-c2aa-45ee-8245-b122888aec05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9a2895c0-9aff-42a6-8af1-0522eb101863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7ecc48cf-c2aa-45ee-8245-b122888aec05" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9a2895c0-9aff-42a6-8af1-0522eb101863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_063e7b14-ab53-4245-bd35-4257908db322" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9a2895c0-9aff-42a6-8af1-0522eb101863" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_063e7b14-ab53-4245-bd35-4257908db322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7024ac2a-d972-4a8b-aeec-3f36b55af2c8" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_UpfrontLicenseFeeAmountPaid_833f7d3b-488d-4961-a5b1-167f00bac349" xlink:href="dare-20211231.xsd#dare_UpfrontLicenseFeeAmountPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_dare_UpfrontLicenseFeeAmountPaid_833f7d3b-488d-4961-a5b1-167f00bac349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d85145ca-8e75-4ce7-803d-e2f7fe8bff57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d85145ca-8e75-4ce7-803d-e2f7fe8bff57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_MilestonePaymentsContingentAmount_6d8f15f2-8747-42aa-a51d-767be50ec33a" xlink:href="dare-20211231.xsd#dare_MilestonePaymentsContingentAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_dare_MilestonePaymentsContingentAmount_6d8f15f2-8747-42aa-a51d-767be50ec33a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_LicenseFee_d7619098-0b07-4239-995b-0dd7b1454b59" xlink:href="dare-20211231.xsd#dare_LicenseFee"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_dare_LicenseFee_d7619098-0b07-4239-995b-0dd7b1454b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_AssetAcquisitionContingentConsideration_d7510724-adbc-463e-812e-a0c76070e426" xlink:href="dare-20211231.xsd#dare_AssetAcquisitionContingentConsideration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_dare_AssetAcquisitionContingentConsideration_d7510724-adbc-463e-812e-a0c76070e426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_RoyaltyAgreementTerm_f712670e-0302-408c-bd02-268a374e17fb" xlink:href="dare-20211231.xsd#dare_RoyaltyAgreementTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_dare_RoyaltyAgreementTerm_f712670e-0302-408c-bd02-268a374e17fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_LicenseAgreementTerminationPeriodicDiscontinuedSaleOfProduct_1cc9af6d-ed57-4ec0-be6e-1e4f26f93809" xlink:href="dare-20211231.xsd#dare_LicenseAgreementTerminationPeriodicDiscontinuedSaleOfProduct"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_dare_LicenseAgreementTerminationPeriodicDiscontinuedSaleOfProduct_1cc9af6d-ed57-4ec0-be6e-1e4f26f93809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_LicenseAgreementTerminationPeriodDueToPerformanceFailure_14cfb8b0-d9fb-444d-b739-674f8dfb3be9" xlink:href="dare-20211231.xsd#dare_LicenseAgreementTerminationPeriodDueToPerformanceFailure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_dare_LicenseAgreementTerminationPeriodDueToPerformanceFailure_14cfb8b0-d9fb-444d-b739-674f8dfb3be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_LicenseAgreementNoticePeriodOfTermination_6fa76787-aaaa-44d0-9576-26dd10dae26e" xlink:href="dare-20211231.xsd#dare_LicenseAgreementNoticePeriodOfTermination"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_dare_LicenseAgreementNoticePeriodOfTermination_6fa76787-aaaa-44d0-9576-26dd10dae26e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_LicenseFeeToBePaidUponContingency_88691217-c5d3-40f9-ba6f-fc974c866cbf" xlink:href="dare-20211231.xsd#dare_LicenseFeeToBePaidUponContingency"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_dare_LicenseFeeToBePaidUponContingency_88691217-c5d3-40f9-ba6f-fc974c866cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_ResearchAndDevelopmentMilestonePayment_915fcd73-414e-45e5-8b90-d6887ac963bc" xlink:href="dare-20211231.xsd#dare_ResearchAndDevelopmentMilestonePayment"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_dare_ResearchAndDevelopmentMilestonePayment_915fcd73-414e-45e5-8b90-d6887ac963bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_PercentageOfRoyaltyRate_465a6894-658e-4156-8252-99b95b5c6c00" xlink:href="dare-20211231.xsd#dare_PercentageOfRoyaltyRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_dare_PercentageOfRoyaltyRate_465a6894-658e-4156-8252-99b95b5c6c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_PercentageOfRightsToInventionsByEmployeesUnderLicenseAgreement_2ee3497c-1b2c-420b-9ae4-f9b3c7ff9d9f" xlink:href="dare-20211231.xsd#dare_PercentageOfRightsToInventionsByEmployeesUnderLicenseAgreement"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_dare_PercentageOfRightsToInventionsByEmployeesUnderLicenseAgreement_2ee3497c-1b2c-420b-9ae4-f9b3c7ff9d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_PotentialAnnualLicenseMaintenanceFeePaymentsInYearOne_a0cac6b5-b2db-4d45-b7ed-f8de5161d0c8" xlink:href="dare-20211231.xsd#dare_PotentialAnnualLicenseMaintenanceFeePaymentsInYearOne"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_dare_PotentialAnnualLicenseMaintenanceFeePaymentsInYearOne_a0cac6b5-b2db-4d45-b7ed-f8de5161d0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_PotentialAnnualLicenseMaintenanceFeePaymentsThereafter_9a2af2ed-588b-43c8-be9e-2a946050cab2" xlink:href="dare-20211231.xsd#dare_PotentialAnnualLicenseMaintenanceFeePaymentsThereafter"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_dare_PotentialAnnualLicenseMaintenanceFeePaymentsThereafter_9a2af2ed-588b-43c8-be9e-2a946050cab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_MaximumPotentialMilestonePayments_911b0b3e-81d8-4cc2-9b78-eb3f3590e34a" xlink:href="dare-20211231.xsd#dare_MaximumPotentialMilestonePayments"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_dare_MaximumPotentialMilestonePayments_911b0b3e-81d8-4cc2-9b78-eb3f3590e34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostMaintenance_3a5ebed5-5aac-4758-9f05-7b1ed334f133" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostMaintenance"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_us-gaap_CostMaintenance_3a5ebed5-5aac-4758-9f05-7b1ed334f133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_MilestonePaymentsContingentAmountPayableNet_0b2538e0-a35d-404e-9b12-146692ac5c76" xlink:href="dare-20211231.xsd#dare_MilestonePaymentsContingentAmountPayableNet"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_dare_MilestonePaymentsContingentAmountPayableNet_0b2538e0-a35d-404e-9b12-146692ac5c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_01ce470f-be42-4d2e-acc7-4897d695de6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_01ce470f-be42-4d2e-acc7-4897d695de6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_a3121721-d107-4c8c-854c-fcb020e86b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_a3121721-d107-4c8c-854c-fcb020e86b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_1da788b7-821b-4545-9834-828730a8e33b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_1da788b7-821b-4545-9834-828730a8e33b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_fef437b1-3805-4780-a2d7-0b3e37678731" xlink:href="dare-20211231.xsd#dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_fef437b1-3805-4780-a2d7-0b3e37678731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0c9a4241-b1a4-4d5c-be27-b14bce352e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0c9a4241-b1a4-4d5c-be27-b14bce352e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_AssetAcquisitionContingentConsiderationCurrent_8fbc62b1-e957-4f2d-b748-7c81a61d96c1" xlink:href="dare-20211231.xsd#dare_AssetAcquisitionContingentConsiderationCurrent"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_dare_AssetAcquisitionContingentConsiderationCurrent_8fbc62b1-e957-4f2d-b748-7c81a61d96c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RegistrationPaymentArrangementMaximumPotentialConsideration_8ae38bba-e9d7-441c-b6c7-3f9f6a921b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RegistrationPaymentArrangementMaximumPotentialConsideration"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_us-gaap_RegistrationPaymentArrangementMaximumPotentialConsideration_8ae38bba-e9d7-441c-b6c7-3f9f6a921b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_c3b78113-d5f9-4c88-bcb6-6029fdca2e91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_c3b78113-d5f9-4c88-bcb6-6029fdca2e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_PaymentsToStockholdersRepresentativeInBusinessCombination_08933177-3339-49d6-b728-75f7bc9ca816" xlink:href="dare-20211231.xsd#dare_PaymentsToStockholdersRepresentativeInBusinessCombination"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_dare_PaymentsToStockholdersRepresentativeInBusinessCombination_08933177-3339-49d6-b728-75f7bc9ca816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_PaymentOfAdditionalConsiderationInBusinessCombination_d28f663f-d2ef-46db-ab79-623869968051" xlink:href="dare-20211231.xsd#dare_PaymentOfAdditionalConsiderationInBusinessCombination"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6231cd-c960-44fe-adf8-d638bb9cc442" xlink:to="loc_dare_PaymentOfAdditionalConsiderationInBusinessCombination_d28f663f-d2ef-46db-ab79-623869968051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/PrepaidExpenses" xlink:type="simple" xlink:href="dare-20211231.xsd#PrepaidExpenses"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/PrepaidExpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_fef2eedc-57b1-465f-b548-0135a88ccdb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsTextBlock_6951ff6b-756d-41f0-a372-b6843d816eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_fef2eedc-57b1-465f-b548-0135a88ccdb4" xlink:to="loc_us-gaap_OtherCurrentAssetsTextBlock_6951ff6b-756d-41f0-a372-b6843d816eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/PrepaidExpensesTables" xlink:type="simple" xlink:href="dare-20211231.xsd#PrepaidExpensesTables"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/PrepaidExpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_3af37e4e-03a8-419f-9c9f-d7892d29f195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_e3cb0011-d5c9-457a-87b7-eb44b4a993dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_3af37e4e-03a8-419f-9c9f-d7892d29f195" xlink:to="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_e3cb0011-d5c9-457a-87b7-eb44b4a993dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/PrepaidExpensesDetails" xlink:type="simple" xlink:href="dare-20211231.xsd#PrepaidExpensesDetails"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/PrepaidExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_a03e18e0-555a-4148-b1f0-2a4db2028746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_PrepaidClinicalExpense_c34e26bd-97de-494c-baa8-4b35cd1f7db3" xlink:href="dare-20211231.xsd#dare_PrepaidClinicalExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_a03e18e0-555a-4148-b1f0-2a4db2028746" xlink:to="loc_dare_PrepaidClinicalExpense_c34e26bd-97de-494c-baa8-4b35cd1f7db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_ec8ad361-0670-4098-a807-abebdfd98594" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidInsurance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_a03e18e0-555a-4148-b1f0-2a4db2028746" xlink:to="loc_us-gaap_PrepaidInsurance_ec8ad361-0670-4098-a807-abebdfd98594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_PrepaidProfessionalExpense_12dbe57b-0336-4aaf-88d1-2f76ef86e17a" xlink:href="dare-20211231.xsd#dare_PrepaidProfessionalExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_a03e18e0-555a-4148-b1f0-2a4db2028746" xlink:to="loc_dare_PrepaidProfessionalExpense_12dbe57b-0336-4aaf-88d1-2f76ef86e17a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_1013f231-34b9-40d7-87a3-175a3f84b6ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_a03e18e0-555a-4148-b1f0-2a4db2028746" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_1013f231-34b9-40d7-87a3-175a3f84b6ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/OtherNonCurrentAssets" xlink:type="simple" xlink:href="dare-20211231.xsd#OtherNonCurrentAssets"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/OtherNonCurrentAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentDisclosureAbstract_e2b78233-3ad3-4abb-8807-fff950a4b7af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrentDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_OtherAssetsNoncurrentDisclosureTextBlock_307f26df-557a-4f5e-b50b-f80afedd1ad3" xlink:href="dare-20211231.xsd#dare_OtherAssetsNoncurrentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentDisclosureAbstract_e2b78233-3ad3-4abb-8807-fff950a4b7af" xlink:to="loc_dare_OtherAssetsNoncurrentDisclosureTextBlock_307f26df-557a-4f5e-b50b-f80afedd1ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/OtherNonCurrentAssetsTables" xlink:type="simple" xlink:href="dare-20211231.xsd#OtherNonCurrentAssetsTables"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/OtherNonCurrentAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentDisclosureAbstract_97780cd4-e77d-479f-8dee-6c666a4417c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrentDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_561fe385-b74d-41fb-a66d-388fff26740c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentDisclosureAbstract_97780cd4-e77d-479f-8dee-6c666a4417c9" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_561fe385-b74d-41fb-a66d-388fff26740c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/OtherNonCurrentAssetsScheduleofOtherNonCurrentAssetsDetail" xlink:type="simple" xlink:href="dare-20211231.xsd#OtherNonCurrentAssetsScheduleofOtherNonCurrentAssetsDetail"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/OtherNonCurrentAssetsScheduleofOtherNonCurrentAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentDisclosureAbstract_699986cd-ff11-44cd-85cd-0af8901cb145" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrentDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_PrepaidInsuranceNoncurrent_e5502de3-3aa6-4ae9-a16e-a2a1b3b39601" xlink:href="dare-20211231.xsd#dare_PrepaidInsuranceNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentDisclosureAbstract_699986cd-ff11-44cd-85cd-0af8901cb145" xlink:to="loc_dare_PrepaidInsuranceNoncurrent_e5502de3-3aa6-4ae9-a16e-a2a1b3b39601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_03da9dc2-cc1c-4bc0-9a04-321799e6404c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentDisclosureAbstract_699986cd-ff11-44cd-85cd-0af8901cb145" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_03da9dc2-cc1c-4bc0-9a04-321799e6404c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_357b1d48-47c8-40b0-a0ab-382bac219791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentDisclosureAbstract_699986cd-ff11-44cd-85cd-0af8901cb145" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_357b1d48-47c8-40b0-a0ab-382bac219791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_OperatingLeaseRightOfUseAssetNoncurrent_4743183a-f15c-4622-89f9-3d562ffa0fa5" xlink:href="dare-20211231.xsd#dare_OperatingLeaseRightOfUseAssetNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentDisclosureAbstract_699986cd-ff11-44cd-85cd-0af8901cb145" xlink:to="loc_dare_OperatingLeaseRightOfUseAssetNoncurrent_4743183a-f15c-4622-89f9-3d562ffa0fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9c623dae-f1ff-4b3a-b257-9b4eb03aa8c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentDisclosureAbstract_699986cd-ff11-44cd-85cd-0af8901cb145" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9c623dae-f1ff-4b3a-b257-9b4eb03aa8c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/AccruedExpenses" xlink:type="simple" xlink:href="dare-20211231.xsd#AccruedExpenses"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/AccruedExpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_4932e041-c715-48bd-93f4-a6ea2b53c06d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_16533630-bb84-4586-8d39-2511eee1b824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_4932e041-c715-48bd-93f4-a6ea2b53c06d" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_16533630-bb84-4586-8d39-2511eee1b824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="dare-20211231.xsd#AccruedExpensesTables"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/AccruedExpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_64f0362d-b4ba-4a7a-b4ab-50c3643e2c30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_826bb324-0e90-4519-b873-209aa7dc7970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_64f0362d-b4ba-4a7a-b4ab-50c3643e2c30" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_826bb324-0e90-4519-b873-209aa7dc7970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/AccruedExpensesScheduleofAccountsPayableandAccruedExpensesDetail" xlink:type="simple" xlink:href="dare-20211231.xsd#AccruedExpensesScheduleofAccountsPayableandAccruedExpensesDetail"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/AccruedExpensesScheduleofAccountsPayableandAccruedExpensesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_934b5ee4-d6a9-4168-8f25-9a375ebc8643" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f33d25a8-be75-4884-a07b-9e20919bbb3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_934b5ee4-d6a9-4168-8f25-9a375ebc8643" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f33d25a8-be75-4884-a07b-9e20919bbb3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_03c6ab01-a70f-4d48-8195-fec0598f400d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_934b5ee4-d6a9-4168-8f25-9a375ebc8643" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_03c6ab01-a70f-4d48-8195-fec0598f400d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_AccruedLicenseExpense_0def05c2-019d-45a1-a9bb-f30dc8c57ef2" xlink:href="dare-20211231.xsd#dare_AccruedLicenseExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_934b5ee4-d6a9-4168-8f25-9a375ebc8643" xlink:to="loc_dare_AccruedLicenseExpense_0def05c2-019d-45a1-a9bb-f30dc8c57ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_b90b7131-f3ff-4073-9738-deedc2292dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_934b5ee4-d6a9-4168-8f25-9a375ebc8643" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_b90b7131-f3ff-4073-9738-deedc2292dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_d9f0da2e-1263-4aa3-9924-0f0f387b6114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_934b5ee4-d6a9-4168-8f25-9a375ebc8643" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_d9f0da2e-1263-4aa3-9924-0f0f387b6114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/VendorConcentration" xlink:type="simple" xlink:href="dare-20211231.xsd#VendorConcentration"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/VendorConcentration" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_582a8d39-77db-4bf1-ad54-d59c6a0c7201" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_4e688b40-f53a-427c-a719-462d54128c48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_582a8d39-77db-4bf1-ad54-d59c6a0c7201" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_4e688b40-f53a-427c-a719-462d54128c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/VendorConcentrationDetails" xlink:type="simple" xlink:href="dare-20211231.xsd#VendorConcentrationDetails"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/VendorConcentrationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_0b32c454-b055-4ad5-86b2-37012f775600" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_2625f98e-6fa4-4c24-9a47-98d81cb40da3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_0b32c454-b055-4ad5-86b2-37012f775600" xlink:to="loc_us-gaap_ConcentrationRiskTable_2625f98e-6fa4-4c24-9a47-98d81cb40da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_babae6c0-51fb-4b7e-bdd6-03966af9718a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_2625f98e-6fa4-4c24-9a47-98d81cb40da3" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_babae6c0-51fb-4b7e-bdd6-03966af9718a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_22c61e39-b013-4524-869f-bb2c02e01eca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_babae6c0-51fb-4b7e-bdd6-03966af9718a" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_22c61e39-b013-4524-869f-bb2c02e01eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_6e3c6859-c2b5-4426-9510-9053d855296b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_22c61e39-b013-4524-869f-bb2c02e01eca" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_6e3c6859-c2b5-4426-9510-9053d855296b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_036d62e9-3aa6-4172-aafd-420735f31d98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_2625f98e-6fa4-4c24-9a47-98d81cb40da3" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_036d62e9-3aa6-4172-aafd-420735f31d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0c97782c-f186-4a38-ba20-03722c3a0ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_036d62e9-3aa6-4172-aafd-420735f31d98" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0c97782c-f186-4a38-ba20-03722c3a0ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_b7ac5e3c-f7e0-4e26-93c2-38c275b417b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0c97782c-f186-4a38-ba20-03722c3a0ed0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_b7ac5e3c-f7e0-4e26-93c2-38c275b417b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_d3a57e38-a2ec-4695-88fa-89500b9bdee4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0c97782c-f186-4a38-ba20-03722c3a0ed0" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_d3a57e38-a2ec-4695-88fa-89500b9bdee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_aca3caaf-567b-47af-957c-017cbbac3604" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_2625f98e-6fa4-4c24-9a47-98d81cb40da3" xlink:to="loc_srt_MajorCustomersAxis_aca3caaf-567b-47af-957c-017cbbac3604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_a31ef2d0-eb5d-47c9-842d-aaa0967025ec" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_aca3caaf-567b-47af-957c-017cbbac3604" xlink:to="loc_srt_NameOfMajorCustomerDomain_a31ef2d0-eb5d-47c9-842d-aaa0967025ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_MajorVendorMember_ef9cf3f3-b583-4298-8572-3166c6f98092" xlink:href="dare-20211231.xsd#dare_MajorVendorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_a31ef2d0-eb5d-47c9-842d-aaa0967025ec" xlink:to="loc_dare_MajorVendorMember_ef9cf3f3-b583-4298-8572-3166c6f98092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_3da7c12c-366a-418f-94e3-31c5ff373a07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_2625f98e-6fa4-4c24-9a47-98d81cb40da3" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_3da7c12c-366a-418f-94e3-31c5ff373a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_e5679d02-c6eb-49ea-a7a2-c866a6847610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_3da7c12c-366a-418f-94e3-31c5ff373a07" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_e5679d02-c6eb-49ea-a7a2-c866a6847610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/IncomeTaxes" xlink:type="simple" xlink:href="dare-20211231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8974cd81-cb50-4e34-9307-ca24f072359b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_6e3dfd5f-b73b-406b-bb20-8468dbe7234e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8974cd81-cb50-4e34-9307-ca24f072359b" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_6e3dfd5f-b73b-406b-bb20-8468dbe7234e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="dare-20211231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_83af31cc-4be6-45e0-88e0-cbdb52bdc983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_88e9b3ec-c86a-432d-960f-2eac7ccf3258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_83af31cc-4be6-45e0-88e0-cbdb52bdc983" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_88e9b3ec-c86a-432d-960f-2eac7ccf3258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0bcb92bd-caa5-4a74-b74b-a113feb746e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_83af31cc-4be6-45e0-88e0-cbdb52bdc983" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0bcb92bd-caa5-4a74-b74b-a113feb746e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_9a4c6cf9-6cef-4297-a512-3fff22392dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_83af31cc-4be6-45e0-88e0-cbdb52bdc983" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_9a4c6cf9-6cef-4297-a512-3fff22392dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_71d5941d-589c-4d9b-aed3-3d3862167d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_83af31cc-4be6-45e0-88e0-cbdb52bdc983" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_71d5941d-589c-4d9b-aed3-3d3862167d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/IncomeTaxesSummaryofComponentsofLossfromContinuingOperationsBeforeProvisionforIncomeTaxesDetail" xlink:type="simple" xlink:href="dare-20211231.xsd#IncomeTaxesSummaryofComponentsofLossfromContinuingOperationsBeforeProvisionforIncomeTaxesDetail"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/IncomeTaxesSummaryofComponentsofLossfromContinuingOperationsBeforeProvisionforIncomeTaxesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_85e4eada-41fd-4a95-b67a-ca850f1d20d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_f51ac45f-97df-4aa2-aee2-a0bd287ed7b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_85e4eada-41fd-4a95-b67a-ca850f1d20d7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_f51ac45f-97df-4aa2-aee2-a0bd287ed7b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_f805492b-644e-4e77-8dd8-92ef5cdd1b51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_85e4eada-41fd-4a95-b67a-ca850f1d20d7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_f805492b-644e-4e77-8dd8-92ef5cdd1b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ca29c42d-6148-4a08-875e-e01a03d439a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_85e4eada-41fd-4a95-b67a-ca850f1d20d7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ca29c42d-6148-4a08-875e-e01a03d439a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesBenefitandAmountComputedbyApplyingUSFederalIncomeTaxRateDetail" xlink:type="simple" xlink:href="dare-20211231.xsd#IncomeTaxesReconciliationofProvisionforIncomeTaxesBenefitandAmountComputedbyApplyingUSFederalIncomeTaxRateDetail"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesBenefitandAmountComputedbyApplyingUSFederalIncomeTaxRateDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5382b479-71b0-4749-85aa-1816f7da313d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_ffc9a638-2d2f-49ff-b6d8-4df471445d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5382b479-71b0-4749-85aa-1816f7da313d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_ffc9a638-2d2f-49ff-b6d8-4df471445d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_26023c0e-cd1c-4f82-afc0-6ebee0527f04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5382b479-71b0-4749-85aa-1816f7da313d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_26023c0e-cd1c-4f82-afc0-6ebee0527f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_EffectiveIncomeTaxRateReconciliationPermanentDifferences_1caed16e-8660-41db-a9fe-c115e734c09d" xlink:href="dare-20211231.xsd#dare_EffectiveIncomeTaxRateReconciliationPermanentDifferences"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5382b479-71b0-4749-85aa-1816f7da313d" xlink:to="loc_dare_EffectiveIncomeTaxRateReconciliationPermanentDifferences_1caed16e-8660-41db-a9fe-c115e734c09d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_11a2257a-1382-496e-9da9-e267925deb5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5382b479-71b0-4749-85aa-1816f7da313d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_11a2257a-1382-496e-9da9-e267925deb5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_aee7d009-a5cf-48ae-9955-ec1d1410ace4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5382b479-71b0-4749-85aa-1816f7da313d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_aee7d009-a5cf-48ae-9955-ec1d1410ace4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther_bcfa2e02-2d28-4866-9970-c489b2625595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5382b479-71b0-4749-85aa-1816f7da313d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther_bcfa2e02-2d28-4866-9970-c489b2625595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_342b9917-af3f-4a4b-a3d0-bd2313e9dffe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5382b479-71b0-4749-85aa-1816f7da313d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_342b9917-af3f-4a4b-a3d0-bd2313e9dffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_73438659-1760-4ac4-9b2c-f17fabfbcdbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5382b479-71b0-4749-85aa-1816f7da313d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_73438659-1760-4ac4-9b2c-f17fabfbcdbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/IncomeTaxesSummaryofMajorComponentsofCompanysDeferredTaxAssetsDetail" xlink:type="simple" xlink:href="dare-20211231.xsd#IncomeTaxesSummaryofMajorComponentsofCompanysDeferredTaxAssetsDetail"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/IncomeTaxesSummaryofMajorComponentsofCompanysDeferredTaxAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f9faca4a-cd7e-443a-b8a3-e1bfb5b6e0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_6db05db8-a91d-4b3b-bc1b-854d7b7466a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f9faca4a-cd7e-443a-b8a3-e1bfb5b6e0b9" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_6db05db8-a91d-4b3b-bc1b-854d7b7466a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_183cc0e1-5d7b-44c0-b0f9-c00fac22cbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f9faca4a-cd7e-443a-b8a3-e1bfb5b6e0b9" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_183cc0e1-5d7b-44c0-b0f9-c00fac22cbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCost_08408b03-3029-4fc1-87fc-9b76118dc588" xlink:href="dare-20211231.xsd#dare_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f9faca4a-cd7e-443a-b8a3-e1bfb5b6e0b9" xlink:to="loc_dare_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCost_08408b03-3029-4fc1-87fc-9b76118dc588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_872db783-10fa-4404-9995-adf69d273c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f9faca4a-cd7e-443a-b8a3-e1bfb5b6e0b9" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_872db783-10fa-4404-9995-adf69d273c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2bf55cb3-b058-4260-8493-271f8e3860d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f9faca4a-cd7e-443a-b8a3-e1bfb5b6e0b9" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2bf55cb3-b058-4260-8493-271f8e3860d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_1174d68d-dcce-4aca-ac98-ee073d6fa8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f9faca4a-cd7e-443a-b8a3-e1bfb5b6e0b9" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_1174d68d-dcce-4aca-ac98-ee073d6fa8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_1bda78e8-78aa-4918-ae11-549012f13d26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f9faca4a-cd7e-443a-b8a3-e1bfb5b6e0b9" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_1bda78e8-78aa-4918-ae11-549012f13d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_2c9ef04a-b7b0-4cbb-990f-e505db23eead" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f9faca4a-cd7e-443a-b8a3-e1bfb5b6e0b9" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_2c9ef04a-b7b0-4cbb-990f-e505db23eead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="simple" xlink:href="dare-20211231.xsd#IncomeTaxesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_02cd5db7-4ffd-447b-aa54-26452c5ba2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_d713b5e6-2d07-442b-99a0-11f9a421403b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_02cd5db7-4ffd-447b-aa54-26452c5ba2e3" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_d713b5e6-2d07-442b-99a0-11f9a421403b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_98240420-3c26-420c-a7c2-f6c2fd4d25f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_d713b5e6-2d07-442b-99a0-11f9a421403b" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_98240420-3c26-420c-a7c2-f6c2fd4d25f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_fe67cda2-4356-40d3-99fc-d16b4c9a6a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_98240420-3c26-420c-a7c2-f6c2fd4d25f7" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_fe67cda2-4356-40d3-99fc-d16b4c9a6a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_edb6f1e0-e5cf-4e8a-a96e-d3a2f5992c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_fe67cda2-4356-40d3-99fc-d16b4c9a6a53" xlink:to="loc_us-gaap_DomesticCountryMember_edb6f1e0-e5cf-4e8a-a96e-d3a2f5992c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_c4429335-74e6-48ad-94a8-fbc7b36cbb2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_fe67cda2-4356-40d3-99fc-d16b4c9a6a53" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_c4429335-74e6-48ad-94a8-fbc7b36cbb2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_37ac15d3-4691-4f50-a820-bd6555b169d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_d713b5e6-2d07-442b-99a0-11f9a421403b" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_37ac15d3-4691-4f50-a820-bd6555b169d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_4ce619b2-0b15-45c6-bd54-167f05e1d3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_37ac15d3-4691-4f50-a820-bd6555b169d5" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_4ce619b2-0b15-45c6-bd54-167f05e1d3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_059a4c77-1872-4ef1-9950-5e941f3fc7b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_4ce619b2-0b15-45c6-bd54-167f05e1d3e8" xlink:to="loc_us-gaap_ResearchMember_059a4c77-1872-4ef1-9950-5e941f3fc7b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_9ba9acb5-62dc-44ee-b166-cbeff00ce977" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_d713b5e6-2d07-442b-99a0-11f9a421403b" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_9ba9acb5-62dc-44ee-b166-cbeff00ce977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_2e738cf7-a397-4f1f-b21a-7e733ebba922" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_9ba9acb5-62dc-44ee-b166-cbeff00ce977" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_2e738cf7-a397-4f1f-b21a-7e733ebba922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_8bb81eba-5f7c-406f-b71b-303a88153018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_9ba9acb5-62dc-44ee-b166-cbeff00ce977" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_8bb81eba-5f7c-406f-b71b-303a88153018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_4f03c1c0-0b02-4e31-bc81-b02220d1a2ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_9ba9acb5-62dc-44ee-b166-cbeff00ce977" xlink:to="loc_us-gaap_OperatingLossCarryforwards_4f03c1c0-0b02-4e31-bc81-b02220d1a2ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_20a76a89-dd21-4a3f-a6d5-fc0e4061ebcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_9ba9acb5-62dc-44ee-b166-cbeff00ce977" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_20a76a89-dd21-4a3f-a6d5-fc0e4061ebcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_OperatingLossCarryforwardsExpirationPeriod_b8ded09f-93a2-410c-8b45-541d19dad808" xlink:href="dare-20211231.xsd#dare_OperatingLossCarryforwardsExpirationPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_9ba9acb5-62dc-44ee-b166-cbeff00ce977" xlink:to="loc_dare_OperatingLossCarryforwardsExpirationPeriod_b8ded09f-93a2-410c-8b45-541d19dad808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_e6c03540-40d2-40ef-bd15-026515e2e558" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_9ba9acb5-62dc-44ee-b166-cbeff00ce977" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_e6c03540-40d2-40ef-bd15-026515e2e558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_463c836a-3d16-4238-aa27-e3699eae13ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_9ba9acb5-62dc-44ee-b166-cbeff00ce977" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_463c836a-3d16-4238-aa27-e3699eae13ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_TaxCreditCarryForwardSubjectToExpiration_ee02767b-df5a-4140-8fbc-7f464dbb7a35" xlink:href="dare-20211231.xsd#dare_TaxCreditCarryForwardSubjectToExpiration"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_9ba9acb5-62dc-44ee-b166-cbeff00ce977" xlink:to="loc_dare_TaxCreditCarryForwardSubjectToExpiration_ee02767b-df5a-4140-8fbc-7f464dbb7a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_TaxCreditCarryforwardExpirationPeriod_0949a8b5-0d54-4317-a8cf-122640b2464c" xlink:href="dare-20211231.xsd#dare_TaxCreditCarryforwardExpirationPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_9ba9acb5-62dc-44ee-b166-cbeff00ce977" xlink:to="loc_dare_TaxCreditCarryforwardExpirationPeriod_0949a8b5-0d54-4317-a8cf-122640b2464c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_f0e6440d-c67b-4d27-99a2-e35eafb2a83c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_9ba9acb5-62dc-44ee-b166-cbeff00ce977" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_f0e6440d-c67b-4d27-99a2-e35eafb2a83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_b88ead35-bf72-40df-9e58-0d1fe41c9065" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_9ba9acb5-62dc-44ee-b166-cbeff00ce977" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_b88ead35-bf72-40df-9e58-0d1fe41c9065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_UnremittedEarnings_571faccd-67e3-4898-b74d-8ac870e5dbec" xlink:href="dare-20211231.xsd#dare_UnremittedEarnings"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_9ba9acb5-62dc-44ee-b166-cbeff00ce977" xlink:to="loc_dare_UnremittedEarnings_571faccd-67e3-4898-b74d-8ac870e5dbec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/IncomeTaxesSummaryofReconciliationofBeginningandEndingAmountofUncertainTaxBenefitsDetail" xlink:type="simple" xlink:href="dare-20211231.xsd#IncomeTaxesSummaryofReconciliationofBeginningandEndingAmountofUncertainTaxBenefitsDetail"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/IncomeTaxesSummaryofReconciliationofBeginningandEndingAmountofUncertainTaxBenefitsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_80e0bd0a-ed40-497b-870c-f66874b3caa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f943a1b4-f5aa-4c66-bd2a-e250a9f9e875" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_80e0bd0a-ed40-497b-870c-f66874b3caa8" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f943a1b4-f5aa-4c66-bd2a-e250a9f9e875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_834cadd0-4c68-4999-8289-302c0e29e798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f943a1b4-f5aa-4c66-bd2a-e250a9f9e875" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_834cadd0-4c68-4999-8289-302c0e29e798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_72eaf8ff-9e43-4328-8d64-165774f6e3e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f943a1b4-f5aa-4c66-bd2a-e250a9f9e875" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_72eaf8ff-9e43-4328-8d64-165774f6e3e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_c9989c06-ff31-47b5-9053-f63531f86798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f943a1b4-f5aa-4c66-bd2a-e250a9f9e875" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_c9989c06-ff31-47b5-9053-f63531f86798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_ccb83b0b-3de6-4a01-a488-0a8150420ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f943a1b4-f5aa-4c66-bd2a-e250a9f9e875" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_ccb83b0b-3de6-4a01-a488-0a8150420ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/StockholdersEquity" xlink:type="simple" xlink:href="dare-20211231.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e7421af9-c369-44dc-9f99-574e7c7ced0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_5b820999-6d7e-4133-9183-a941f5de1176" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e7421af9-c369-44dc-9f99-574e7c7ced0a" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_5b820999-6d7e-4133-9183-a941f5de1176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="dare-20211231.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2ac4a820-b7e2-426a-85c7-a48e8245d2ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_3221afde-4ae3-46c7-9e83-40385e75bcf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2ac4a820-b7e2-426a-85c7-a48e8245d2ff" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_3221afde-4ae3-46c7-9e83-40385e75bcf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_17fbfd24-bbad-44d3-8a96-d0c879c0c7a2" xlink:href="dare-20211231.xsd#dare_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2ac4a820-b7e2-426a-85c7-a48e8245d2ff" xlink:to="loc_dare_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_17fbfd24-bbad-44d3-8a96-d0c879c0c7a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/StockholdersEquityAdditionalInformationDetail" xlink:type="simple" xlink:href="dare-20211231.xsd#StockholdersEquityAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockholdersEquityAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_27ea210b-447e-418b-9798-820a43fbc67a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_0f1973be-3b6d-4884-8c20-dd0fa3b28e58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_27ea210b-447e-418b-9798-820a43fbc67a" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_0f1973be-3b6d-4884-8c20-dd0fa3b28e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_72f9119a-eacf-4513-8c43-7780f7c4e598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0f1973be-3b6d-4884-8c20-dd0fa3b28e58" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_72f9119a-eacf-4513-8c43-7780f7c4e598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5f504272-c74e-454e-901c-096cb303e71b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_72f9119a-eacf-4513-8c43-7780f7c4e598" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5f504272-c74e-454e-901c-096cb303e71b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_April2021AtTheMarketSalesAgreementMember_12f919b6-b199-494d-b1f2-d0238e680235" xlink:href="dare-20211231.xsd#dare_April2021AtTheMarketSalesAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5f504272-c74e-454e-901c-096cb303e71b" xlink:to="loc_dare_April2021AtTheMarketSalesAgreementMember_12f919b6-b199-494d-b1f2-d0238e680235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_A2018AtTheMarketSalesAgreementMember_5ec6ab75-a0af-47d3-9e1b-443fc05c629e" xlink:href="dare-20211231.xsd#dare_A2018AtTheMarketSalesAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5f504272-c74e-454e-901c-096cb303e71b" xlink:to="loc_dare_A2018AtTheMarketSalesAgreementMember_5ec6ab75-a0af-47d3-9e1b-443fc05c629e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_PurchaseAgreementMember_94fce74e-429e-4a5e-bf35-4a748620f41a" xlink:href="dare-20211231.xsd#dare_PurchaseAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5f504272-c74e-454e-901c-096cb303e71b" xlink:to="loc_dare_PurchaseAgreementMember_94fce74e-429e-4a5e-bf35-4a748620f41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4ee24840-27e8-4ffc-aca1-7b4a2478bcf9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0f1973be-3b6d-4884-8c20-dd0fa3b28e58" xlink:to="loc_srt_RangeAxis_4ee24840-27e8-4ffc-aca1-7b4a2478bcf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_421bb738-af38-4eae-970b-9e5ccd86c92a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4ee24840-27e8-4ffc-aca1-7b4a2478bcf9" xlink:to="loc_srt_RangeMember_421bb738-af38-4eae-970b-9e5ccd86c92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a0bf90fb-f901-47ed-bee6-111b608b7f82" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_421bb738-af38-4eae-970b-9e5ccd86c92a" xlink:to="loc_srt_MaximumMember_a0bf90fb-f901-47ed-bee6-111b608b7f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_6160615b-d4ad-487f-b2a4-e28a434281bf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0f1973be-3b6d-4884-8c20-dd0fa3b28e58" xlink:to="loc_dei_LegalEntityAxis_6160615b-d4ad-487f-b2a4-e28a434281bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_946d62d3-89c5-445a-8abf-7549da856bd9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_6160615b-d4ad-487f-b2a4-e28a434281bf" xlink:to="loc_dei_EntityDomain_946d62d3-89c5-445a-8abf-7549da856bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_LincolnParkMember_2b0ef924-ffc5-41ac-8c63-7881558592f7" xlink:href="dare-20211231.xsd#dare_LincolnParkMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_946d62d3-89c5-445a-8abf-7549da856bd9" xlink:to="loc_dare_LincolnParkMember_2b0ef924-ffc5-41ac-8c63-7881558592f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_7dab8df3-db6e-4b71-91da-6f8b0715a02e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0f1973be-3b6d-4884-8c20-dd0fa3b28e58" xlink:to="loc_srt_CounterpartyNameAxis_7dab8df3-db6e-4b71-91da-6f8b0715a02e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_03f6c30a-f9fd-4520-998c-6f3dce5c9098" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_7dab8df3-db6e-4b71-91da-6f8b0715a02e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_03f6c30a-f9fd-4520-998c-6f3dce5c9098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_LincolnParkMember_956bf114-0e72-4aeb-8f35-b86f75e0100b" xlink:href="dare-20211231.xsd#dare_LincolnParkMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_03f6c30a-f9fd-4520-998c-6f3dce5c9098" xlink:to="loc_dare_LincolnParkMember_956bf114-0e72-4aeb-8f35-b86f75e0100b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_6060b881-ae24-476d-bef0-b277c0b2c02c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0f1973be-3b6d-4884-8c20-dd0fa3b28e58" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_6060b881-ae24-476d-bef0-b277c0b2c02c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_f29bab28-04ea-4ed4-bdca-99af8e4663b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_6060b881-ae24-476d-bef0-b277c0b2c02c" xlink:to="loc_us-gaap_TypeOfAdoptionMember_f29bab28-04ea-4ed4-bdca-99af8e4663b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201711Member_d36f3a62-b720-4560-aaab-350de9ae8ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201711Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_f29bab28-04ea-4ed4-bdca-99af8e4663b1" xlink:to="loc_us-gaap_AccountingStandardsUpdate201711Member_d36f3a62-b720-4560-aaab-350de9ae8ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0f1973be-3b6d-4884-8c20-dd0fa3b28e58" xlink:to="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_PercentageOfAggregateCommission_8059219c-b613-42e9-a15e-8958cbd5a74f" xlink:href="dare-20211231.xsd#dare_PercentageOfAggregateCommission"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_dare_PercentageOfAggregateCommission_8059219c-b613-42e9-a15e-8958cbd5a74f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7b5229cc-019a-4e62-8112-83c13b90611d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_us-gaap_CommonStockValue_7b5229cc-019a-4e62-8112-83c13b90611d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_eb6c0f8f-f090-486d-86f2-4a68f342ee99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_eb6c0f8f-f090-486d-86f2-4a68f342ee99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_bdefd89a-b298-4c8f-96e5-7d062e31f7ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_bdefd89a-b298-4c8f-96e5-7d062e31f7ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_OfferingExpenses_c580a975-7c58-43c0-a067-18317d9ecf8e" xlink:href="dare-20211231.xsd#dare_OfferingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_dare_OfferingExpenses_c580a975-7c58-43c0-a067-18317d9ecf8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_68fa6854-0c08-4e82-84a7-a33f0b80d1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_us-gaap_PurchaseObligation_68fa6854-0c08-4e82-84a7-a33f0b80d1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts_e48bc269-4501-4532-8cea-bd5ed78e99df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_us-gaap_DeferredOfferingCosts_e48bc269-4501-4532-8cea-bd5ed78e99df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_DeferredOfferingCostsUnamortizedPortion_7edf8656-7ec6-438b-846e-4178bb9ce150" xlink:href="dare-20211231.xsd#dare_DeferredOfferingCostsUnamortizedPortion"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_dare_DeferredOfferingCostsUnamortizedPortion_7edf8656-7ec6-438b-846e-4178bb9ce150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_e9bc9434-9941-4edf-a089-80821586e9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_e9bc9434-9941-4edf-a089-80821586e9cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_855d45a8-9b51-4dd7-8fb2-31f8a08c5636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_855d45a8-9b51-4dd7-8fb2-31f8a08c5636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_RegularRepurchaseCommonStockIssuable_aad64b4e-6e26-4a7c-aec9-5dbe017236b9" xlink:href="dare-20211231.xsd#dare_RegularRepurchaseCommonStockIssuable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_dare_RegularRepurchaseCommonStockIssuable_aad64b4e-6e26-4a7c-aec9-5dbe017236b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8ec01f2b-9bd5-4ac9-8a62-bacfd7a62288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8ec01f2b-9bd5-4ac9-8a62-bacfd7a62288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_EstimatedFairValueOfWarrantsRecordedInEquity_7c2e6153-5346-4567-a83a-83b9b092b10d" xlink:href="dare-20211231.xsd#dare_EstimatedFairValueOfWarrantsRecordedInEquity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_dare_EstimatedFairValueOfWarrantsRecordedInEquity_7c2e6153-5346-4567-a83a-83b9b092b10d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantExercisePriceDecrease_49f5670c-119a-43ee-8480-7c0dfc107928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantExercisePriceDecrease"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_us-gaap_WarrantExercisePriceDecrease_49f5670c-119a-43ee-8480-7c0dfc107928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_DeemedDividendFromTriggerOfRoundDownProvisionFeature_cc2037dc-d127-43d4-bfc1-216b77cd6583" xlink:href="dare-20211231.xsd#dare_DeemedDividendFromTriggerOfRoundDownProvisionFeature"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_dare_DeemedDividendFromTriggerOfRoundDownProvisionFeature_cc2037dc-d127-43d4-bfc1-216b77cd6583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_NumberOfCommonStockWarrantsExercised_6b478ed7-54ec-46cf-9ddf-a569e90befe7" xlink:href="dare-20211231.xsd#dare_NumberOfCommonStockWarrantsExercised"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_dare_NumberOfCommonStockWarrantsExercised_6b478ed7-54ec-46cf-9ddf-a569e90befe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_edcd543d-5dbf-4bb9-8a92-18858c34c34c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_edcd543d-5dbf-4bb9-8a92-18858c34c34c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_2b304ff2-c9ac-4d67-bcc1-660c3240ebbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_2b304ff2-c9ac-4d67-bcc1-660c3240ebbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_d7cca24b-7e53-4348-890a-2c847c22457a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_d7cca24b-7e53-4348-890a-2c847c22457a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_cc4679ab-310a-48a9-bc93-07020af61715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_cc4679ab-310a-48a9-bc93-07020af61715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_44f40d1e-9fb7-4d27-9e77-3c3c18bc3c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_44f40d1e-9fb7-4d27-9e77-3c3c18bc3c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_21b493bc-c055-481f-afcd-9ac66789399b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_us-gaap_CommonStockSharesIssued_21b493bc-c055-481f-afcd-9ac66789399b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_12c71fab-935f-4f53-874a-a381b38e9f47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_12c71fab-935f-4f53-874a-a381b38e9f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_964b8174-6127-4a2e-bdf0-d68b61bdf2e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1e2991b-188e-4ec1-9ba4-5c60efffeb76" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_964b8174-6127-4a2e-bdf0-d68b61bdf2e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/StockholdersEquityScheduleofCommonStockWarrantsOutstandingDetails" xlink:type="simple" xlink:href="dare-20211231.xsd#StockholdersEquityScheduleofCommonStockWarrantsOutstandingDetails"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockholdersEquityScheduleofCommonStockWarrantsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_1b55adcb-3116-4291-97f8-511a4b20ce5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_d3bb4190-4444-4e30-8f13-b69b76a0a38c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1b55adcb-3116-4291-97f8-511a4b20ce5a" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_d3bb4190-4444-4e30-8f13-b69b76a0a38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_5b12fe13-3a33-408c-b545-5043a702991d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d3bb4190-4444-4e30-8f13-b69b76a0a38c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_5b12fe13-3a33-408c-b545-5043a702991d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_84ec691c-885a-4a3b-b60d-9c78209eabf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_5b12fe13-3a33-408c-b545-5043a702991d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_84ec691c-885a-4a3b-b60d-9c78209eabf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_WarrantsExpiringOnAprilFourTwoThousandTwentySixMember_1919280c-d2dd-42fa-a674-b464ed058b0d" xlink:href="dare-20211231.xsd#dare_WarrantsExpiringOnAprilFourTwoThousandTwentySixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_84ec691c-885a-4a3b-b60d-9c78209eabf0" xlink:to="loc_dare_WarrantsExpiringOnAprilFourTwoThousandTwentySixMember_1919280c-d2dd-42fa-a674-b464ed058b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_WarrantsExpiringOnFebruaryFifteenTwoThousandTwentyThreeMember_4f34d9ce-0152-41b6-9ff6-b61c02975222" xlink:href="dare-20211231.xsd#dare_WarrantsExpiringOnFebruaryFifteenTwoThousandTwentyThreeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_84ec691c-885a-4a3b-b60d-9c78209eabf0" xlink:to="loc_dare_WarrantsExpiringOnFebruaryFifteenTwoThousandTwentyThreeMember_4f34d9ce-0152-41b6-9ff6-b61c02975222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_de84929c-2b40-49a5-8146-5146f74e81e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d3bb4190-4444-4e30-8f13-b69b76a0a38c" xlink:to="loc_us-gaap_ClassOfStockLineItems_de84929c-2b40-49a5-8146-5146f74e81e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_4019f672-ce6a-4a31-bd55-05de9dbd2251" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_de84929c-2b40-49a5-8146-5146f74e81e4" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_4019f672-ce6a-4a31-bd55-05de9dbd2251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_e5be5dcd-4835-44e8-9023-cc2facc99f05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_de84929c-2b40-49a5-8146-5146f74e81e4" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_e5be5dcd-4835-44e8-9023-cc2facc99f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_ClassOfWarrantOrRightsWarrantsExpirationDate_71f244bb-166a-4d4f-9662-899a3642d3cc" xlink:href="dare-20211231.xsd#dare_ClassOfWarrantOrRightsWarrantsExpirationDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_de84929c-2b40-49a5-8146-5146f74e81e4" xlink:to="loc_dare_ClassOfWarrantOrRightsWarrantsExpirationDate_71f244bb-166a-4d4f-9662-899a3642d3cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail" xlink:type="simple" xlink:href="dare-20211231.xsd#StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_43a411b5-56e6-4fe6-9026-064ccafef1ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_b9a89465-7fd4-4837-a10f-e0604ea849b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_43a411b5-56e6-4fe6-9026-064ccafef1ca" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_b9a89465-7fd4-4837-a10f-e0604ea849b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_dfdf7616-fb28-4bde-8381-3cfad59aae7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b9a89465-7fd4-4837-a10f-e0604ea849b0" xlink:to="loc_us-gaap_PlanNameAxis_dfdf7616-fb28-4bde-8381-3cfad59aae7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4256c5f6-39ab-47fd-b531-ed332237370e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_dfdf7616-fb28-4bde-8381-3cfad59aae7c" xlink:to="loc_us-gaap_PlanNameDomain_4256c5f6-39ab-47fd-b531-ed332237370e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_AmendedAndRestatedTwoThousandFourteenStockIncentivePlanMember_e57beaf8-6c3a-453a-8baa-6a43be8e1448" xlink:href="dare-20211231.xsd#dare_AmendedAndRestatedTwoThousandFourteenStockIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_4256c5f6-39ab-47fd-b531-ed332237370e" xlink:to="loc_dare_AmendedAndRestatedTwoThousandFourteenStockIncentivePlanMember_e57beaf8-6c3a-453a-8baa-6a43be8e1448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5c9bd949-bfe3-4625-8fcf-25b11ff698c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b9a89465-7fd4-4837-a10f-e0604ea849b0" xlink:to="loc_us-gaap_AwardTypeAxis_5c9bd949-bfe3-4625-8fcf-25b11ff698c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b06ac628-3d87-4c9d-83fd-e4146ee12541" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5c9bd949-bfe3-4625-8fcf-25b11ff698c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b06ac628-3d87-4c9d-83fd-e4146ee12541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_ExerciseOfWarrantsOutstandingMember_a94b740b-9fd1-4848-9388-37c5074d8ed4" xlink:href="dare-20211231.xsd#dare_ExerciseOfWarrantsOutstandingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b06ac628-3d87-4c9d-83fd-e4146ee12541" xlink:to="loc_dare_ExerciseOfWarrantsOutstandingMember_a94b740b-9fd1-4848-9388-37c5074d8ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_ExerciseOfOptionsOutstandingMember_66ac42a2-5fc4-419e-85b2-60cb7ce1ffe2" xlink:href="dare-20211231.xsd#dare_ExerciseOfOptionsOutstandingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b06ac628-3d87-4c9d-83fd-e4146ee12541" xlink:to="loc_dare_ExerciseOfOptionsOutstandingMember_66ac42a2-5fc4-419e-85b2-60cb7ce1ffe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d86b63eb-cb44-42b7-878f-123bc6a779bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b06ac628-3d87-4c9d-83fd-e4146ee12541" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d86b63eb-cb44-42b7-878f-123bc6a779bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_e4e15336-c387-41f5-967f-7dbc6e5af1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b9a89465-7fd4-4837-a10f-e0604ea849b0" xlink:to="loc_us-gaap_ClassOfStockLineItems_e4e15336-c387-41f5-967f-7dbc6e5af1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7e139c98-285d-4369-8362-4a4f5348dc64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e4e15336-c387-41f5-967f-7dbc6e5af1c8" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7e139c98-285d-4369-8362-4a4f5348dc64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="dare-20211231.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9a4b0e9c-3647-4282-8e09-cc3e55a34f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_af4532db-9dd5-488e-8d3f-4f20f3cb423a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9a4b0e9c-3647-4282-8e09-cc3e55a34f1b" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_af4532db-9dd5-488e-8d3f-4f20f3cb423a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/StockbasedCompensationTables" xlink:type="simple" xlink:href="dare-20211231.xsd#StockbasedCompensationTables"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockbasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_76833575-128d-4765-b14e-31e35c0f64aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e97e1281-5768-4272-a952-e239813a7d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_76833575-128d-4765-b14e-31e35c0f64aa" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e97e1281-5768-4272-a952-e239813a7d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_4ebb55ad-510e-4ccb-8e1b-0b961060faa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_76833575-128d-4765-b14e-31e35c0f64aa" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_4ebb55ad-510e-4ccb-8e1b-0b961060faa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_a006a586-3e7d-4c7f-9bf8-185cb2529e93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_76833575-128d-4765-b14e-31e35c0f64aa" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_a006a586-3e7d-4c7f-9bf8-185cb2529e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/StockbasedcompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="dare-20211231.xsd#StockbasedcompensationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockbasedcompensationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e277fb34-e6f0-416d-9f04-fe95c9358283" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_158b34e6-1f80-4f37-b04f-3528e041fc55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e277fb34-e6f0-416d-9f04-fe95c9358283" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_158b34e6-1f80-4f37-b04f-3528e041fc55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_1db454ec-1fc1-47b4-abf1-53617813d565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_158b34e6-1f80-4f37-b04f-3528e041fc55" xlink:to="loc_us-gaap_PlanNameAxis_1db454ec-1fc1-47b4-abf1-53617813d565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f6f8eaa9-045c-45f3-a5d2-e3d7bfc1f8c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_1db454ec-1fc1-47b4-abf1-53617813d565" xlink:to="loc_us-gaap_PlanNameDomain_f6f8eaa9-045c-45f3-a5d2-e3d7bfc1f8c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_TwoThousandAndFourteenEmployeeStockPurchasePlanMember_9771abd0-66b7-4bc6-9c04-91c97386e852" xlink:href="dare-20211231.xsd#dare_TwoThousandAndFourteenEmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_f6f8eaa9-045c-45f3-a5d2-e3d7bfc1f8c6" xlink:to="loc_dare_TwoThousandAndFourteenEmployeeStockPurchasePlanMember_9771abd0-66b7-4bc6-9c04-91c97386e852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_AmendedAndRestatedTwoThousandFourteenStockIncentivePlanMember_aaafaa07-b1b5-4105-9b3c-8d1f8566c575" xlink:href="dare-20211231.xsd#dare_AmendedAndRestatedTwoThousandFourteenStockIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_f6f8eaa9-045c-45f3-a5d2-e3d7bfc1f8c6" xlink:to="loc_dare_AmendedAndRestatedTwoThousandFourteenStockIncentivePlanMember_aaafaa07-b1b5-4105-9b3c-8d1f8566c575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_TwoThousandAndFifteenStockIncentivePlanMember_fb60e5d5-2bca-4620-8d03-87e7ca561939" xlink:href="dare-20211231.xsd#dare_TwoThousandAndFifteenStockIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_f6f8eaa9-045c-45f3-a5d2-e3d7bfc1f8c6" xlink:to="loc_dare_TwoThousandAndFifteenStockIncentivePlanMember_fb60e5d5-2bca-4620-8d03-87e7ca561939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_479e6976-a8cc-4dfa-8e28-6cad0c9cd2be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_158b34e6-1f80-4f37-b04f-3528e041fc55" xlink:to="loc_us-gaap_AwardTypeAxis_479e6976-a8cc-4dfa-8e28-6cad0c9cd2be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_748d84d7-00b7-4a73-83e8-0969378c16f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_479e6976-a8cc-4dfa-8e28-6cad0c9cd2be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_748d84d7-00b7-4a73-83e8-0969378c16f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_70bd0ae0-8654-44d7-9383-15c25b3b9a24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_748d84d7-00b7-4a73-83e8-0969378c16f5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_70bd0ae0-8654-44d7-9383-15c25b3b9a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_2ef3612a-04dc-40fa-82eb-5d461a111ee2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_158b34e6-1f80-4f37-b04f-3528e041fc55" xlink:to="loc_dei_LegalEntityAxis_2ef3612a-04dc-40fa-82eb-5d461a111ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_beee5e7f-49fb-4575-b2d1-dc0c4f5f71d0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_2ef3612a-04dc-40fa-82eb-5d461a111ee2" xlink:to="loc_dei_EntityDomain_beee5e7f-49fb-4575-b2d1-dc0c4f5f71d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_PrivateDareMember_c8c82289-2aba-4ecc-afa6-20cc753f1d88" xlink:href="dare-20211231.xsd#dare_PrivateDareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_beee5e7f-49fb-4575-b2d1-dc0c4f5f71d0" xlink:to="loc_dare_PrivateDareMember_c8c82289-2aba-4ecc-afa6-20cc753f1d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4de20226-0068-4b7a-b14b-17f9804b5c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_158b34e6-1f80-4f37-b04f-3528e041fc55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4de20226-0068-4b7a-b14b-17f9804b5c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_146f77c4-fa48-4475-b32e-eef1351cbc7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4de20226-0068-4b7a-b14b-17f9804b5c6a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_146f77c4-fa48-4475-b32e-eef1351cbc7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4c3b8722-a9c4-4c9f-9f9e-344a092bc45c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4de20226-0068-4b7a-b14b-17f9804b5c6a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4c3b8722-a9c4-4c9f-9f9e-344a092bc45c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_15a4dc70-15ad-42cd-acfb-51c4caf8d5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4de20226-0068-4b7a-b14b-17f9804b5c6a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_15a4dc70-15ad-42cd-acfb-51c4caf8d5c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_1f2b8ce8-aa88-4be9-978b-0982c6f53911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4de20226-0068-4b7a-b14b-17f9804b5c6a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_1f2b8ce8-aa88-4be9-978b-0982c6f53911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease_06ccacec-7052-4141-bd28-bb56738eb3b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4de20226-0068-4b7a-b14b-17f9804b5c6a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease_06ccacec-7052-4141-bd28-bb56738eb3b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_6c055b24-e09e-43ef-a921-28f6bf8a4d36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4de20226-0068-4b7a-b14b-17f9804b5c6a" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_6c055b24-e09e-43ef-a921-28f6bf8a4d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_ef412707-34a8-4246-8ea1-2919afb33d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4de20226-0068-4b7a-b14b-17f9804b5c6a" xlink:to="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_ef412707-34a8-4246-8ea1-2919afb33d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_WeightedAverageAmortizationPeriod_366a7a9d-266c-43ee-93cf-a386e443965c" xlink:href="dare-20211231.xsd#dare_WeightedAverageAmortizationPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4de20226-0068-4b7a-b14b-17f9804b5c6a" xlink:to="loc_dare_WeightedAverageAmortizationPeriod_366a7a9d-266c-43ee-93cf-a386e443965c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/StockbasedCompensationSummaryofStockOptionActivityDetail" xlink:type="simple" xlink:href="dare-20211231.xsd#StockbasedCompensationSummaryofStockOptionActivityDetail"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockbasedCompensationSummaryofStockOptionActivityDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1ddf9351-a0a5-4a5a-ad4a-214622978372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_36bff09e-f5ea-4e5b-8d87-18aaf51b1bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1ddf9351-a0a5-4a5a-ad4a-214622978372" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_36bff09e-f5ea-4e5b-8d87-18aaf51b1bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_f9065d38-da21-453b-ae58-c44ac908e0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_36bff09e-f5ea-4e5b-8d87-18aaf51b1bc2" xlink:to="loc_us-gaap_PlanNameAxis_f9065d38-da21-453b-ae58-c44ac908e0cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3253077b-f154-487e-b2ad-4df589abd202" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_f9065d38-da21-453b-ae58-c44ac908e0cb" xlink:to="loc_us-gaap_PlanNameDomain_3253077b-f154-487e-b2ad-4df589abd202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_AmendedAndRestatedTwoThousandFourteenStockIncentivePlanMember_3b714df3-f0c2-43ac-9303-b49425bbfa9c" xlink:href="dare-20211231.xsd#dare_AmendedAndRestatedTwoThousandFourteenStockIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3253077b-f154-487e-b2ad-4df589abd202" xlink:to="loc_dare_AmendedAndRestatedTwoThousandFourteenStockIncentivePlanMember_3b714df3-f0c2-43ac-9303-b49425bbfa9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_TwoThousandAndFifteenStockIncentivePlanMember_bae6656f-ebdd-436f-a05d-e88590df13ad" xlink:href="dare-20211231.xsd#dare_TwoThousandAndFifteenStockIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3253077b-f154-487e-b2ad-4df589abd202" xlink:to="loc_dare_TwoThousandAndFifteenStockIncentivePlanMember_bae6656f-ebdd-436f-a05d-e88590df13ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3bf9dafb-54e4-454e-9bf1-d0b268a0b3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_36bff09e-f5ea-4e5b-8d87-18aaf51b1bc2" xlink:to="loc_us-gaap_AwardTypeAxis_3bf9dafb-54e4-454e-9bf1-d0b268a0b3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ea12e22d-9a75-4493-a43d-e72472304af6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3bf9dafb-54e4-454e-9bf1-d0b268a0b3c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ea12e22d-9a75-4493-a43d-e72472304af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b220fdbb-f769-478a-84e2-0c94920ae3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ea12e22d-9a75-4493-a43d-e72472304af6" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b220fdbb-f769-478a-84e2-0c94920ae3bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_48149eec-6a9d-4a41-9fad-7bd5755c7497" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_36bff09e-f5ea-4e5b-8d87-18aaf51b1bc2" xlink:to="loc_dei_LegalEntityAxis_48149eec-6a9d-4a41-9fad-7bd5755c7497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b23da5d1-d4c0-4552-a585-73fc00177cb1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_48149eec-6a9d-4a41-9fad-7bd5755c7497" xlink:to="loc_dei_EntityDomain_b23da5d1-d4c0-4552-a585-73fc00177cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_PrivateDareMember_49fc6bb4-3ac9-43a3-820f-e21b46972f6a" xlink:href="dare-20211231.xsd#dare_PrivateDareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_b23da5d1-d4c0-4552-a585-73fc00177cb1" xlink:to="loc_dare_PrivateDareMember_49fc6bb4-3ac9-43a3-820f-e21b46972f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5cf9f2ec-3122-4cb7-a8d2-ff05d8ecf1de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_36bff09e-f5ea-4e5b-8d87-18aaf51b1bc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5cf9f2ec-3122-4cb7-a8d2-ff05d8ecf1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f5177787-71ed-4173-b672-aeacadb59782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5cf9f2ec-3122-4cb7-a8d2-ff05d8ecf1de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f5177787-71ed-4173-b672-aeacadb59782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_01dffb58-f9a2-43ba-a8e6-9e67762255e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f5177787-71ed-4173-b672-aeacadb59782" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_01dffb58-f9a2-43ba-a8e6-9e67762255e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_698cfda2-f555-4bcc-9047-a095dc7baaad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f5177787-71ed-4173-b672-aeacadb59782" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_698cfda2-f555-4bcc-9047-a095dc7baaad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d6aee0c9-2dcb-40a6-98ee-8bd836cef1e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f5177787-71ed-4173-b672-aeacadb59782" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d6aee0c9-2dcb-40a6-98ee-8bd836cef1e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_7ef97003-524f-46d0-a29f-d58cf8cdafe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f5177787-71ed-4173-b672-aeacadb59782" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_7ef97003-524f-46d0-a29f-d58cf8cdafe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_d90f9fc7-e522-4f33-b92d-62c7aa76e5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f5177787-71ed-4173-b672-aeacadb59782" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_d90f9fc7-e522-4f33-b92d-62c7aa76e5b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4f0810bc-d2cb-4b68-9678-0108eb6affa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f5177787-71ed-4173-b672-aeacadb59782" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4f0810bc-d2cb-4b68-9678-0108eb6affa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c6ee48e2-658b-4cf5-aa85-dc22eba41f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5cf9f2ec-3122-4cb7-a8d2-ff05d8ecf1de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c6ee48e2-658b-4cf5-aa85-dc22eba41f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_06bc691c-bff6-45b6-948e-af4031c70885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5cf9f2ec-3122-4cb7-a8d2-ff05d8ecf1de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_06bc691c-bff6-45b6-948e-af4031c70885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_41e37047-4b6c-4efd-96aa-055dc48bb638" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5cf9f2ec-3122-4cb7-a8d2-ff05d8ecf1de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_41e37047-4b6c-4efd-96aa-055dc48bb638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6c79ac82-6050-42cb-bcfe-04f0f5bb1e01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_41e37047-4b6c-4efd-96aa-055dc48bb638" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6c79ac82-6050-42cb-bcfe-04f0f5bb1e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_61a04b93-d4ba-4f88-9180-bbe00af56d92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_41e37047-4b6c-4efd-96aa-055dc48bb638" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_61a04b93-d4ba-4f88-9180-bbe00af56d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_7d1adbbb-2839-49a5-aa84-fa134b23d7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_41e37047-4b6c-4efd-96aa-055dc48bb638" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_7d1adbbb-2839-49a5-aa84-fa134b23d7ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c810008c-bd1b-490e-bbb6-edf070b197cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_41e37047-4b6c-4efd-96aa-055dc48bb638" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c810008c-bd1b-490e-bbb6-edf070b197cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_30c1cbd8-fb4d-4e9c-8d3c-a46e47ca145c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_41e37047-4b6c-4efd-96aa-055dc48bb638" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_30c1cbd8-fb4d-4e9c-8d3c-a46e47ca145c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7a1a81c6-4d32-4ccc-9a05-d25a4cc15a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_41e37047-4b6c-4efd-96aa-055dc48bb638" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7a1a81c6-4d32-4ccc-9a05-d25a4cc15a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ef7871fc-f3ce-4e9d-bc78-2e779889fa8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5cf9f2ec-3122-4cb7-a8d2-ff05d8ecf1de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ef7871fc-f3ce-4e9d-bc78-2e779889fa8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_89bb0acb-0e6f-4037-b9a8-be75d586633a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5cf9f2ec-3122-4cb7-a8d2-ff05d8ecf1de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_89bb0acb-0e6f-4037-b9a8-be75d586633a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollForward_3a5a9ff6-4f4b-41de-a5e2-66db09e0b80b" xlink:href="dare-20211231.xsd#dare_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollForward"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5cf9f2ec-3122-4cb7-a8d2-ff05d8ecf1de" xlink:to="loc_dare_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollForward_3a5a9ff6-4f4b-41de-a5e2-66db09e0b80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_4da6902d-1356-4759-a692-ff8260345763" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollForward_3a5a9ff6-4f4b-41de-a5e2-66db09e0b80b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_4da6902d-1356-4759-a692-ff8260345763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_21a04f37-effb-40ea-85a5-268f73850cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollForward_3a5a9ff6-4f4b-41de-a5e2-66db09e0b80b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_21a04f37-effb-40ea-85a5-268f73850cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_6523eb81-f92d-4c24-a98a-72e6d71521bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollForward_3a5a9ff6-4f4b-41de-a5e2-66db09e0b80b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_6523eb81-f92d-4c24-a98a-72e6d71521bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForward_8e4c7574-e2df-485b-b5f7-af89f28b3808" xlink:href="dare-20211231.xsd#dare_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForward"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5cf9f2ec-3122-4cb7-a8d2-ff05d8ecf1de" xlink:to="loc_dare_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForward_8e4c7574-e2df-485b-b5f7-af89f28b3808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_76996aa8-2345-43cc-89f7-09bdd44bd2db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForward_8e4c7574-e2df-485b-b5f7-af89f28b3808" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_76996aa8-2345-43cc-89f7-09bdd44bd2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_bc6ab844-9951-43da-8404-1696d5452bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForward_8e4c7574-e2df-485b-b5f7-af89f28b3808" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_bc6ab844-9951-43da-8404-1696d5452bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0adacc14-fd42-4b13-ac79-f61e5f1f4263" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForward_8e4c7574-e2df-485b-b5f7-af89f28b3808" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0adacc14-fd42-4b13-ac79-f61e5f1f4263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/StockbasedCompensationCompensationExpenseDetails" xlink:type="simple" xlink:href="dare-20211231.xsd#StockbasedCompensationCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockbasedCompensationCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6f846004-c3bf-49b1-ac74-e679db843463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1002a45b-aad4-4d27-a8a8-943b582c2503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6f846004-c3bf-49b1-ac74-e679db843463" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1002a45b-aad4-4d27-a8a8-943b582c2503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_70126f5e-c1fd-4822-b485-3ea261ec31a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1002a45b-aad4-4d27-a8a8-943b582c2503" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_70126f5e-c1fd-4822-b485-3ea261ec31a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_366cc4f1-aad3-4fdf-9f88-672d99699a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_70126f5e-c1fd-4822-b485-3ea261ec31a8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_366cc4f1-aad3-4fdf-9f88-672d99699a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a8317afc-aec1-4ce7-899e-41ee671c4a45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_366cc4f1-aad3-4fdf-9f88-672d99699a9b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a8317afc-aec1-4ce7-899e-41ee671c4a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_e112cd13-5e6e-45fe-9b78-6e5c3af54c38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_366cc4f1-aad3-4fdf-9f88-672d99699a9b" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_e112cd13-5e6e-45fe-9b78-6e5c3af54c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_645e6d46-0d42-40f7-a59d-b0a4f3dbcee3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1002a45b-aad4-4d27-a8a8-943b582c2503" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_645e6d46-0d42-40f7-a59d-b0a4f3dbcee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_84fa065d-7a2f-41bb-896f-93c993dabb68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_645e6d46-0d42-40f7-a59d-b0a4f3dbcee3" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_84fa065d-7a2f-41bb-896f-93c993dabb68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/StockbasedCompensationSummaryofAssumptionsUsedinBlackScholesOptionPricingModelforStockOptionsGrantedtoEmployeesandNonEmployeeDirectorsDetail" xlink:type="simple" xlink:href="dare-20211231.xsd#StockbasedCompensationSummaryofAssumptionsUsedinBlackScholesOptionPricingModelforStockOptionsGrantedtoEmployeesandNonEmployeeDirectorsDetail"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockbasedCompensationSummaryofAssumptionsUsedinBlackScholesOptionPricingModelforStockOptionsGrantedtoEmployeesandNonEmployeeDirectorsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0acaab8a-e33d-4b93-beae-d0f41b1926f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_c01578cc-2277-43cb-91f4-f8278bf69d30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0acaab8a-e33d-4b93-beae-d0f41b1926f1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_c01578cc-2277-43cb-91f4-f8278bf69d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_213c13fc-7c25-4f17-83f6-29be512ffff3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0acaab8a-e33d-4b93-beae-d0f41b1926f1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_213c13fc-7c25-4f17-83f6-29be512ffff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_d9934291-8fe7-4003-85c5-9600956a8984" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0acaab8a-e33d-4b93-beae-d0f41b1926f1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_d9934291-8fe7-4003-85c5-9600956a8984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_249fa994-5883-4f59-a7e4-36d9dcd80322" xlink:href="dare-20211231.xsd#dare_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0acaab8a-e33d-4b93-beae-d0f41b1926f1" xlink:to="loc_dare_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_249fa994-5883-4f59-a7e4-36d9dcd80322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_028ddde1-72a4-42f8-ac01-c87cbc77235c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0acaab8a-e33d-4b93-beae-d0f41b1926f1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_028ddde1-72a4-42f8-ac01-c87cbc77235c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_702467a7-53f5-4695-b518-959401ea1424" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0acaab8a-e33d-4b93-beae-d0f41b1926f1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_702467a7-53f5-4695-b518-959401ea1424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/LeasedProperties" xlink:type="simple" xlink:href="dare-20211231.xsd#LeasedProperties"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/LeasedProperties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_040f9ff6-870b-4fe8-b908-404745383a34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_1d014432-ba50-40a0-a5ad-87a7011d77c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_040f9ff6-870b-4fe8-b908-404745383a34" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_1d014432-ba50-40a0-a5ad-87a7011d77c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/LeasedPropertiesTables" xlink:type="simple" xlink:href="dare-20211231.xsd#LeasedPropertiesTables"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/LeasedPropertiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_179b50a1-a36f-4d12-9534-5eedbf9e3fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_25a668e6-6189-4bc9-8303-898d9057089f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_179b50a1-a36f-4d12-9534-5eedbf9e3fdf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_25a668e6-6189-4bc9-8303-898d9057089f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/LeasedPropertiesAdditionalInformationDetails" xlink:type="simple" xlink:href="dare-20211231.xsd#LeasedPropertiesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/LeasedPropertiesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_8d023576-7dfd-4e2f-b412-b7b7a919c81c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_4a69bba4-124c-479d-8048-f779a2e8c948" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8d023576-7dfd-4e2f-b412-b7b7a919c81c" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_4a69bba4-124c-479d-8048-f779a2e8c948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_125f688f-d2c4-407a-96b5-73f0f3c2e5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4a69bba4-124c-479d-8048-f779a2e8c948" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_125f688f-d2c4-407a-96b5-73f0f3c2e5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7c2b6a7d-71f3-4845-982b-87a70e5b974a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_125f688f-d2c4-407a-96b5-73f0f3c2e5ae" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7c2b6a7d-71f3-4845-982b-87a70e5b974a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_fc6a76c4-d46c-44fb-bd10-7badbf9e63e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7c2b6a7d-71f3-4845-982b-87a70e5b974a" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_fc6a76c4-d46c-44fb-bd10-7badbf9e63e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4ab809a9-913d-4e60-8918-5fe2a03ca334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4a69bba4-124c-479d-8048-f779a2e8c948" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4ab809a9-913d-4e60-8918-5fe2a03ca334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4b29b956-0322-4221-8e83-b677cf622377" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4ab809a9-913d-4e60-8918-5fe2a03ca334" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4b29b956-0322-4221-8e83-b677cf622377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d076f9d9-3bf4-4535-92fc-dcad6cd70e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_4b29b956-0322-4221-8e83-b677cf622377" xlink:to="loc_us-gaap_SubsequentEventMember_d076f9d9-3bf4-4535-92fc-dcad6cd70e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_521ba2c2-085f-4371-b033-f31e99aec055" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4a69bba4-124c-479d-8048-f779a2e8c948" xlink:to="loc_dei_LegalEntityAxis_521ba2c2-085f-4371-b033-f31e99aec055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c281ca74-eab0-480a-a79f-46237295cb9b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_521ba2c2-085f-4371-b033-f31e99aec055" xlink:to="loc_dei_EntityDomain_c281ca74-eab0-480a-a79f-46237295cb9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_MBIMember_78baa561-c45b-41f4-9dd5-287fb19c55df" xlink:href="dare-20211231.xsd#dare_MBIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_c281ca74-eab0-480a-a79f-46237295cb9b" xlink:to="loc_dare_MBIMember_78baa561-c45b-41f4-9dd5-287fb19c55df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_967a357e-8748-45c8-a0d4-3312845b8284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4a69bba4-124c-479d-8048-f779a2e8c948" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_967a357e-8748-45c8-a0d4-3312845b8284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetRentableArea_c139793d-c1b9-4dee-9622-98cd8415038c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetRentableArea"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_967a357e-8748-45c8-a0d4-3312845b8284" xlink:to="loc_us-gaap_NetRentableArea_c139793d-c1b9-4dee-9622-98cd8415038c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_969dc729-f18b-4647-9173-66870a4633b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_967a357e-8748-45c8-a0d4-3312845b8284" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_969dc729-f18b-4647-9173-66870a4633b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate_2bb62085-ae30-4ebe-8478-f272de6ef1f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_967a357e-8748-45c8-a0d4-3312845b8284" xlink:to="loc_us-gaap_LesseeOperatingLeaseDiscountRate_2bb62085-ae30-4ebe-8478-f272de6ef1f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_b20f0d17-b1f3-4208-b004-4a7dc83f53c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_967a357e-8748-45c8-a0d4-3312845b8284" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_b20f0d17-b1f3-4208-b004-4a7dc83f53c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ffd65ce8-e68b-4923-9a34-63ca1c1ad211" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_967a357e-8748-45c8-a0d4-3312845b8284" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ffd65ce8-e68b-4923-9a34-63ca1c1ad211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_0020d4af-5c15-4237-bb1e-ade5f26de1bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_967a357e-8748-45c8-a0d4-3312845b8284" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_0020d4af-5c15-4237-bb1e-ade5f26de1bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_a75b3fa2-9c4f-4317-9478-9244d1932f81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_967a357e-8748-45c8-a0d4-3312845b8284" xlink:to="loc_us-gaap_OperatingLeaseCost_a75b3fa2-9c4f-4317-9478-9244d1932f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_9d800822-3f7c-43fe-bc4e-0783c6e8fd5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_967a357e-8748-45c8-a0d4-3312845b8284" xlink:to="loc_us-gaap_OperatingLeasePayments_9d800822-3f7c-43fe-bc4e-0783c6e8fd5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_152108db-fb4c-4e43-87c5-1097bc1f2802" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_967a357e-8748-45c8-a0d4-3312845b8284" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_152108db-fb4c-4e43-87c5-1097bc1f2802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/LeasedPropertiesFutureMinimumLeasePaymentDetails" xlink:type="simple" xlink:href="dare-20211231.xsd#LeasedPropertiesFutureMinimumLeasePaymentDetails"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/LeasedPropertiesFutureMinimumLeasePaymentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_15cb4a46-b64b-4a97-bb75-346385703059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d79f3a24-e55e-4bb0-8f08-5af8e4b89a00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_15cb4a46-b64b-4a97-bb75-346385703059" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d79f3a24-e55e-4bb0-8f08-5af8e4b89a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c163088e-0473-4128-804a-3209429e6721" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_15cb4a46-b64b-4a97-bb75-346385703059" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c163088e-0473-4128-804a-3209429e6721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e601edc3-4faf-42f6-bca4-21b6bbca173d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_15cb4a46-b64b-4a97-bb75-346385703059" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e601edc3-4faf-42f6-bca4-21b6bbca173d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_1868f38e-4158-45a2-abc1-01e63b8a717d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_15cb4a46-b64b-4a97-bb75-346385703059" xlink:to="loc_us-gaap_OperatingLeaseLiability_1868f38e-4158-45a2-abc1-01e63b8a717d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/LeasedPropertiesFutureMinimumLeasePaymentDetails_1" xlink:type="simple" xlink:href="dare-20211231.xsd#LeasedPropertiesFutureMinimumLeasePaymentDetails_1"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/LeasedPropertiesFutureMinimumLeasePaymentDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="dare-20211231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_afdb059f-11b4-4cf4-9fae-05553bbf2ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock_b9da0b0b-8c4e-4820-a411-f054dc9f2489" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_afdb059f-11b4-4cf4-9fae-05553bbf2ce8" xlink:to="loc_us-gaap_CommitmentsDisclosureTextBlock_b9da0b0b-8c4e-4820-a411-f054dc9f2489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="simple" xlink:href="dare-20211231.xsd#CommitmentsandContingenciesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e868a152-c167-4e74-952c-4b43a89409d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_CommitmentsAndContingenciesTable_16cb5813-90ca-41e9-a16e-9598f56d0317" xlink:href="dare-20211231.xsd#dare_CommitmentsAndContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e868a152-c167-4e74-952c-4b43a89409d0" xlink:to="loc_dare_CommitmentsAndContingenciesTable_16cb5813-90ca-41e9-a16e-9598f56d0317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_068a2aa4-eacd-4813-b876-916efade009d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesTable_16cb5813-90ca-41e9-a16e-9598f56d0317" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_068a2aa4-eacd-4813-b876-916efade009d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_686b3ee7-cedb-4487-b70a-759f083e053f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_068a2aa4-eacd-4813-b876-916efade009d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_686b3ee7-cedb-4487-b70a-759f083e053f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_MicrochipsBiotechInc.Member_2ee13e2d-9f0d-4c8f-903d-119d7092eadd" xlink:href="dare-20211231.xsd#dare_MicrochipsBiotechInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_686b3ee7-cedb-4487-b70a-759f083e053f" xlink:to="loc_dare_MicrochipsBiotechInc.Member_2ee13e2d-9f0d-4c8f-903d-119d7092eadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_140639e2-77aa-4069-b753-c5e42254a4de" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesTable_16cb5813-90ca-41e9-a16e-9598f56d0317" xlink:to="loc_srt_RangeAxis_140639e2-77aa-4069-b753-c5e42254a4de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_56a64858-389b-4c50-adae-8e7d8370af4d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_140639e2-77aa-4069-b753-c5e42254a4de" xlink:to="loc_srt_RangeMember_56a64858-389b-4c50-adae-8e7d8370af4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_812ac85f-7536-4e60-a822-f47b8f8d9a28" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_56a64858-389b-4c50-adae-8e7d8370af4d" xlink:to="loc_srt_MinimumMember_812ac85f-7536-4e60-a822-f47b8f8d9a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_50507b20-8b90-4ba0-aa98-4f34218b9403" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_56a64858-389b-4c50-adae-8e7d8370af4d" xlink:to="loc_srt_MaximumMember_50507b20-8b90-4ba0-aa98-4f34218b9403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_8e806748-6ddb-425e-99d4-8251014afcd2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesTable_16cb5813-90ca-41e9-a16e-9598f56d0317" xlink:to="loc_srt_CounterpartyNameAxis_8e806748-6ddb-425e-99d4-8251014afcd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3c6744f5-d558-4a90-be4f-9a894391181e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_8e806748-6ddb-425e-99d4-8251014afcd2" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3c6744f5-d558-4a90-be4f-9a894391181e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_NICHDMember_6ca72e97-986d-43a0-b2b1-5c2ad370e1e2" xlink:href="dare-20211231.xsd#dare_NICHDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3c6744f5-d558-4a90-be4f-9a894391181e" xlink:to="loc_dare_NICHDMember_6ca72e97-986d-43a0-b2b1-5c2ad370e1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_CRADAMember_e933d47d-d640-4d60-a4fb-17d683aec484" xlink:href="dare-20211231.xsd#dare_CRADAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3c6744f5-d558-4a90-be4f-9a894391181e" xlink:to="loc_dare_CRADAMember_e933d47d-d640-4d60-a4fb-17d683aec484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_CommitmentsAndContingenciesLineItems_332ecb20-8d99-4ff6-b40e-e0c2906641b0" xlink:href="dare-20211231.xsd#dare_CommitmentsAndContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesTable_16cb5813-90ca-41e9-a16e-9598f56d0317" xlink:to="loc_dare_CommitmentsAndContingenciesLineItems_332ecb20-8d99-4ff6-b40e-e0c2906641b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_ResearchAndDevelopmentAgreementCommitmentAmount_81043e96-a23e-425f-b410-744b2ad47c78" xlink:href="dare-20211231.xsd#dare_ResearchAndDevelopmentAgreementCommitmentAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_332ecb20-8d99-4ff6-b40e-e0c2906641b0" xlink:to="loc_dare_ResearchAndDevelopmentAgreementCommitmentAmount_81043e96-a23e-425f-b410-744b2ad47c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross_d4284c4a-a29d-439e-a608-531032c842b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_332ecb20-8d99-4ff6-b40e-e0c2906641b0" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross_d4284c4a-a29d-439e-a608-531032c842b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_03ca0b49-5c09-4c20-8a6e-d7d94b52a7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_332ecb20-8d99-4ff6-b40e-e0c2906641b0" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_03ca0b49-5c09-4c20-8a6e-d7d94b52a7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_PaymentOfAdditionalConsiderationInBusinessCombination_1847a7bd-0c10-4dac-b89f-04781a252a4d" xlink:href="dare-20211231.xsd#dare_PaymentOfAdditionalConsiderationInBusinessCombination"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_332ecb20-8d99-4ff6-b40e-e0c2906641b0" xlink:to="loc_dare_PaymentOfAdditionalConsiderationInBusinessCombination_1847a7bd-0c10-4dac-b89f-04781a252a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RegistrationPaymentArrangementMaximumPotentialConsideration_bae79c20-da1c-40e6-b1be-4a6febf63f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RegistrationPaymentArrangementMaximumPotentialConsideration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_332ecb20-8d99-4ff6-b40e-e0c2906641b0" xlink:to="loc_us-gaap_RegistrationPaymentArrangementMaximumPotentialConsideration_bae79c20-da1c-40e6-b1be-4a6febf63f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_AssetAcquisitionContingentConsiderationCurrent_6d73640c-bd61-4a8b-99d5-c29554d3a93d" xlink:href="dare-20211231.xsd#dare_AssetAcquisitionContingentConsiderationCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_332ecb20-8d99-4ff6-b40e-e0c2906641b0" xlink:to="loc_dare_AssetAcquisitionContingentConsiderationCurrent_6d73640c-bd61-4a8b-99d5-c29554d3a93d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f45f9e84-6f6b-4feb-a428-f94c394a18fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_332ecb20-8d99-4ff6-b40e-e0c2906641b0" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_f45f9e84-6f6b-4feb-a428-f94c394a18fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c9343157-7ea9-42cb-9f07-4782419465ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_332ecb20-8d99-4ff6-b40e-e0c2906641b0" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c9343157-7ea9-42cb-9f07-4782419465ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_PaymentsToStockholdersRepresentativeInBusinessCombination_d4e4f142-5ee8-45f1-92c7-72ef439b1c37" xlink:href="dare-20211231.xsd#dare_PaymentsToStockholdersRepresentativeInBusinessCombination"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_332ecb20-8d99-4ff6-b40e-e0c2906641b0" xlink:to="loc_dare_PaymentsToStockholdersRepresentativeInBusinessCombination_d4e4f142-5ee8-45f1-92c7-72ef439b1c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_CoronavirusAidReliefandEconomicSecurityActLoanProceedsReceived_0a640b27-13b9-4766-98a7-59ff6b049cbb" xlink:href="dare-20211231.xsd#dare_CoronavirusAidReliefandEconomicSecurityActLoanProceedsReceived"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_332ecb20-8d99-4ff6-b40e-e0c2906641b0" xlink:to="loc_dare_CoronavirusAidReliefandEconomicSecurityActLoanProceedsReceived_0a640b27-13b9-4766-98a7-59ff6b049cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_NotesPayableCurrentPlusAccruedInterest_493c750e-a7c2-4cca-a2f8-cef7de7b8915" xlink:href="dare-20211231.xsd#dare_NotesPayableCurrentPlusAccruedInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_332ecb20-8d99-4ff6-b40e-e0c2906641b0" xlink:to="loc_dare_NotesPayableCurrentPlusAccruedInterest_493c750e-a7c2-4cca-a2f8-cef7de7b8915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_EmploymentAgreementChangeInControlOfCompanyTerminationWithoutCauseOrResignationForGoodReason_c4f15604-c242-43ad-b3b4-25df9afb5e81" xlink:href="dare-20211231.xsd#dare_EmploymentAgreementChangeInControlOfCompanyTerminationWithoutCauseOrResignationForGoodReason"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_332ecb20-8d99-4ff6-b40e-e0c2906641b0" xlink:to="loc_dare_EmploymentAgreementChangeInControlOfCompanyTerminationWithoutCauseOrResignationForGoodReason_c4f15604-c242-43ad-b3b4-25df9afb5e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_EmploymentAgreementSalaryPaymentReceivedUponTerminationWithoutCause_7b8703ed-a1c2-451b-a97c-f695726a7271" xlink:href="dare-20211231.xsd#dare_EmploymentAgreementSalaryPaymentReceivedUponTerminationWithoutCause"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_332ecb20-8d99-4ff6-b40e-e0c2906641b0" xlink:to="loc_dare_EmploymentAgreementSalaryPaymentReceivedUponTerminationWithoutCause_7b8703ed-a1c2-451b-a97c-f695726a7271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_EmploymentAgreementHealthBenefitsCoverageReceivedUponTerminationWithoutCause_6743088a-8ae3-4d71-a0c5-6e7bf18a866a" xlink:href="dare-20211231.xsd#dare_EmploymentAgreementHealthBenefitsCoverageReceivedUponTerminationWithoutCause"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_332ecb20-8d99-4ff6-b40e-e0c2906641b0" xlink:to="loc_dare_EmploymentAgreementHealthBenefitsCoverageReceivedUponTerminationWithoutCause_6743088a-8ae3-4d71-a0c5-6e7bf18a866a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_EmploymentAgreementChangeInControlOfCompanyTerminationForCauseOrGoodReason_5b18be2b-2ded-4c78-b56c-b65ef11e0fae" xlink:href="dare-20211231.xsd#dare_EmploymentAgreementChangeInControlOfCompanyTerminationForCauseOrGoodReason"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_332ecb20-8d99-4ff6-b40e-e0c2906641b0" xlink:to="loc_dare_EmploymentAgreementChangeInControlOfCompanyTerminationForCauseOrGoodReason_5b18be2b-2ded-4c78-b56c-b65ef11e0fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_EmploymentAgreementSalaryPaymentReceivedUponTerminationForCauseOrGoodReason_748e745b-60a6-4ae8-ab3f-c50ca5ce7eb0" xlink:href="dare-20211231.xsd#dare_EmploymentAgreementSalaryPaymentReceivedUponTerminationForCauseOrGoodReason"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_332ecb20-8d99-4ff6-b40e-e0c2906641b0" xlink:to="loc_dare_EmploymentAgreementSalaryPaymentReceivedUponTerminationForCauseOrGoodReason_748e745b-60a6-4ae8-ab3f-c50ca5ce7eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_EmploymentAgreementHealthBenefitsCoverageReceivedUponTerminationForCauseOrGoodReason_8e91cbf4-98e2-496e-b179-62b73cf190a0" xlink:href="dare-20211231.xsd#dare_EmploymentAgreementHealthBenefitsCoverageReceivedUponTerminationForCauseOrGoodReason"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_332ecb20-8d99-4ff6-b40e-e0c2906641b0" xlink:to="loc_dare_EmploymentAgreementHealthBenefitsCoverageReceivedUponTerminationForCauseOrGoodReason_8e91cbf4-98e2-496e-b179-62b73cf190a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_2251da07-2ccd-4da1-8e37-f589aba178cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_332ecb20-8d99-4ff6-b40e-e0c2906641b0" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_2251da07-2ccd-4da1-8e37-f589aba178cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_e1a983b2-0011-4e97-aaa0-19a43d19af1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_332ecb20-8d99-4ff6-b40e-e0c2906641b0" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_e1a983b2-0011-4e97-aaa0-19a43d19af1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/GrantAwards" xlink:type="simple" xlink:href="dare-20211231.xsd#GrantAwards"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/GrantAwards" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_cc4daf97-7de2-4f60-a04a-20aa903c309d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_GrantAwardTextBlock_059bc3c0-dd23-4a3a-a75b-ce6adb61ff00" xlink:href="dare-20211231.xsd#dare_GrantAwardTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_cc4daf97-7de2-4f60-a04a-20aa903c309d" xlink:to="loc_dare_GrantAwardTextBlock_059bc3c0-dd23-4a3a-a75b-ce6adb61ff00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/GrantAwardsAdditionalInformationDetails" xlink:type="simple" xlink:href="dare-20211231.xsd#GrantAwardsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/GrantAwardsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_eb2baa7c-3e11-4a42-962d-bb3651f2fec9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_413f098e-f223-41a3-967b-1de6ce816a10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_eb2baa7c-3e11-4a42-962d-bb3651f2fec9" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_413f098e-f223-41a3-967b-1de6ce816a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5b95ed52-e698-4d67-a5a3-703a9b7c32f2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_413f098e-f223-41a3-967b-1de6ce816a10" xlink:to="loc_srt_ProductOrServiceAxis_5b95ed52-e698-4d67-a5a3-703a9b7c32f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f6cb2994-1188-489d-8c01-5d5a55708c24" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_5b95ed52-e698-4d67-a5a3-703a9b7c32f2" xlink:to="loc_srt_ProductsAndServicesDomain_f6cb2994-1188-489d-8c01-5d5a55708c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_GrantOvapreneMember_e7e13832-9f6d-4c26-a6f3-623bf1fd8546" xlink:href="dare-20211231.xsd#dare_GrantOvapreneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f6cb2994-1188-489d-8c01-5d5a55708c24" xlink:to="loc_dare_GrantOvapreneMember_e7e13832-9f6d-4c26-a6f3-623bf1fd8546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_GrantDAREPTB1Member_753eae10-d497-4893-92fe-fdc858992f38" xlink:href="dare-20211231.xsd#dare_GrantDAREPTB1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f6cb2994-1188-489d-8c01-5d5a55708c24" xlink:to="loc_dare_GrantDAREPTB1Member_753eae10-d497-4893-92fe-fdc858992f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_DARELARC1Member_7e280af8-9649-413e-ba1a-24e1957c5bac" xlink:href="dare-20211231.xsd#dare_DARELARC1Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f6cb2994-1188-489d-8c01-5d5a55708c24" xlink:to="loc_dare_DARELARC1Member_7e280af8-9649-413e-ba1a-24e1957c5bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember_04f2409d-18c5-4fbf-ba24-45cad1a6e3b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f6cb2994-1188-489d-8c01-5d5a55708c24" xlink:to="loc_us-gaap_GrantMember_04f2409d-18c5-4fbf-ba24-45cad1a6e3b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_84209490-640c-4dfe-9cf3-9e736991d1ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_413f098e-f223-41a3-967b-1de6ce816a10" xlink:to="loc_srt_CounterpartyNameAxis_84209490-640c-4dfe-9cf3-9e736991d1ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_82b9787d-bbd6-4fc0-8b82-165fe1e58bec" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_84209490-640c-4dfe-9cf3-9e736991d1ed" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_82b9787d-bbd6-4fc0-8b82-165fe1e58bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_BillAndMelindaGatesFoundationMember_7549d094-5e57-4bf6-b0a0-6e0b4bfa9b6a" xlink:href="dare-20211231.xsd#dare_BillAndMelindaGatesFoundationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_82b9787d-bbd6-4fc0-8b82-165fe1e58bec" xlink:to="loc_dare_BillAndMelindaGatesFoundationMember_7549d094-5e57-4bf6-b0a0-6e0b4bfa9b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_79d6233d-8144-495e-927f-1b17432ddbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_413f098e-f223-41a3-967b-1de6ce816a10" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_79d6233d-8144-495e-927f-1b17432ddbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_ProceedsFromAwardOfGrant_d02f8ad7-09d2-4b79-81ef-57451f8e60a4" xlink:href="dare-20211231.xsd#dare_ProceedsFromAwardOfGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_79d6233d-8144-495e-927f-1b17432ddbb2" xlink:to="loc_dare_ProceedsFromAwardOfGrant_d02f8ad7-09d2-4b79-81ef-57451f8e60a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred_569e5f29-9054-4f64-b8e5-6a16b9e41ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_79d6233d-8144-495e-927f-1b17432ddbb2" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred_569e5f29-9054-4f64-b8e5-6a16b9e41ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_ReceivableForExpensesEligibleForReimbursement_d6fbc431-27ba-4b38-a859-fbbd626058c5" xlink:href="dare-20211231.xsd#dare_ReceivableForExpensesEligibleForReimbursement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_79d6233d-8144-495e-927f-1b17432ddbb2" xlink:to="loc_dare_ReceivableForExpensesEligibleForReimbursement_d6fbc431-27ba-4b38-a859-fbbd626058c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_AdditionalPotentialFundingRelatedToGrantAward_bd92a33c-0d81-4999-9ae4-fd69bc6d56b9" xlink:href="dare-20211231.xsd#dare_AdditionalPotentialFundingRelatedToGrantAward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_79d6233d-8144-495e-927f-1b17432ddbb2" xlink:to="loc_dare_AdditionalPotentialFundingRelatedToGrantAward_bd92a33c-0d81-4999-9ae4-fd69bc6d56b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDevelopment_0c0b06b6-f161-4c06-8fce-a351148dda4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDevelopment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_79d6233d-8144-495e-927f-1b17432ddbb2" xlink:to="loc_us-gaap_BusinessDevelopment_0c0b06b6-f161-4c06-8fce-a351148dda4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c06cbe7a-8560-41bf-9118-60b0096ec41d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_79d6233d-8144-495e-927f-1b17432ddbb2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c06cbe7a-8560-41bf-9118-60b0096ec41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantsReceivable_8bb24d57-c030-47ae-85d3-4d967e93a959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantsReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_79d6233d-8144-495e-927f-1b17432ddbb2" xlink:to="loc_us-gaap_GrantsReceivable_8bb24d57-c030-47ae-85d3-4d967e93a959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_DeferredGrantFundingCurrent_209e684d-3b51-440f-b1dc-ad43930daa7e" xlink:href="dare-20211231.xsd#dare_DeferredGrantFundingCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_79d6233d-8144-495e-927f-1b17432ddbb2" xlink:to="loc_dare_DeferredGrantFundingCurrent_209e684d-3b51-440f-b1dc-ad43930daa7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/SubsequentEvents" xlink:type="simple" xlink:href="dare-20211231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_edaf7311-81e3-47ed-b3f0-c2d447cbc4a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_e9cc5315-fda4-48f3-b572-ff33b1c4e113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_edaf7311-81e3-47ed-b3f0-c2d447cbc4a4" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_e9cc5315-fda4-48f3-b572-ff33b1c4e113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/SubsequentEventsAdditionalInformationDetail" xlink:type="simple" xlink:href="dare-20211231.xsd#SubsequentEventsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://darebioscience.com/role/SubsequentEventsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_d6e19d8b-5ce1-41b1-91a3-8a6b0bdc6770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_0383649c-b827-4fad-a5b0-7dc521a98d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_d6e19d8b-5ce1-41b1-91a3-8a6b0bdc6770" xlink:to="loc_us-gaap_SubsequentEventTable_0383649c-b827-4fad-a5b0-7dc521a98d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_edff447f-ec01-4a7d-8e0d-7e6833259fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_0383649c-b827-4fad-a5b0-7dc521a98d4f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_edff447f-ec01-4a7d-8e0d-7e6833259fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_385b190f-8bb7-4bd0-aaf7-5d7a9c95471b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_edff447f-ec01-4a7d-8e0d-7e6833259fa0" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_385b190f-8bb7-4bd0-aaf7-5d7a9c95471b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4f024718-b756-4a1c-983a-31e5ec885bca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_385b190f-8bb7-4bd0-aaf7-5d7a9c95471b" xlink:to="loc_us-gaap_SubsequentEventMember_4f024718-b756-4a1c-983a-31e5ec885bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ea553b81-2aa1-4635-bfb4-20534956967b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_0383649c-b827-4fad-a5b0-7dc521a98d4f" xlink:to="loc_srt_CounterpartyNameAxis_ea553b81-2aa1-4635-bfb4-20534956967b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_06e51e2b-c79a-46d9-a773-39ea59ca232d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_ea553b81-2aa1-4635-bfb4-20534956967b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_06e51e2b-c79a-46d9-a773-39ea59ca232d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_OrganonMember_eb57a9b1-a907-4486-b0d3-542bf27c706b" xlink:href="dare-20211231.xsd#dare_OrganonMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_06e51e2b-c79a-46d9-a773-39ea59ca232d" xlink:to="loc_dare_OrganonMember_eb57a9b1-a907-4486-b0d3-542bf27c706b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_198b5eb8-d553-4dd5-9e60-ead902d52aea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_0383649c-b827-4fad-a5b0-7dc521a98d4f" xlink:to="loc_us-gaap_SubsequentEventLineItems_198b5eb8-d553-4dd5-9e60-ead902d52aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_UpfrontLicenseFeeAmountPaid_b9dba2ae-daee-4677-8e19-c14a6d7c7b75" xlink:href="dare-20211231.xsd#dare_UpfrontLicenseFeeAmountPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_198b5eb8-d553-4dd5-9e60-ead902d52aea" xlink:to="loc_dare_UpfrontLicenseFeeAmountPaid_b9dba2ae-daee-4677-8e19-c14a6d7c7b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_MilestonePaymentsContingentAmount_a5be8935-3211-44f6-b3ec-67b4017f1be1" xlink:href="dare-20211231.xsd#dare_MilestonePaymentsContingentAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_198b5eb8-d553-4dd5-9e60-ead902d52aea" xlink:to="loc_dare_MilestonePaymentsContingentAmount_a5be8935-3211-44f6-b3ec-67b4017f1be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_MilestonePaymentsContingentAmountFirstCommercialSaleAmount_99013d40-bd5d-4fec-8ff8-89adf6fb565a" xlink:href="dare-20211231.xsd#dare_MilestonePaymentsContingentAmountFirstCommercialSaleAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_198b5eb8-d553-4dd5-9e60-ead902d52aea" xlink:to="loc_dare_MilestonePaymentsContingentAmountFirstCommercialSaleAmount_99013d40-bd5d-4fec-8ff8-89adf6fb565a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_MilestonePaymentsContingentAmountSalesBasedMilestonesAmount_fb188cf9-f272-4e20-863e-7820f21640a9" xlink:href="dare-20211231.xsd#dare_MilestonePaymentsContingentAmountSalesBasedMilestonesAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_198b5eb8-d553-4dd5-9e60-ead902d52aea" xlink:to="loc_dare_MilestonePaymentsContingentAmountSalesBasedMilestonesAmount_fb188cf9-f272-4e20-863e-7820f21640a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_LicenseAgreementRightToDevelopPeriod_163ec6fe-1cd6-4d8a-ba79-ad8f465a1200" xlink:href="dare-20211231.xsd#dare_LicenseAgreementRightToDevelopPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_198b5eb8-d553-4dd5-9e60-ead902d52aea" xlink:to="loc_dare_LicenseAgreementRightToDevelopPeriod_163ec6fe-1cd6-4d8a-ba79-ad8f465a1200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_LicenseAgreementNoticePeriodOfTermination_70f61d2a-ecb2-4a38-988b-9ee0768d093b" xlink:href="dare-20211231.xsd#dare_LicenseAgreementNoticePeriodOfTermination"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_198b5eb8-d553-4dd5-9e60-ead902d52aea" xlink:to="loc_dare_LicenseAgreementNoticePeriodOfTermination_70f61d2a-ecb2-4a38-988b-9ee0768d093b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_LesseeOperatingLeaseExtensionTerm_4c9b63ab-a86e-45b8-8554-00f1c3d2e788" xlink:href="dare-20211231.xsd#dare_LesseeOperatingLeaseExtensionTerm"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_198b5eb8-d553-4dd5-9e60-ead902d52aea" xlink:to="loc_dare_LesseeOperatingLeaseExtensionTerm_4c9b63ab-a86e-45b8-8554-00f1c3d2e788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
